<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="propionic-a" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">propionic-a</book-part-id>
      <title-group>
        <title>Propionic Acidemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shchelochkov</surname>
            <given-names>Oleg A</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="propionic-a.Tc.aff1"/>
          <email>oleg.shchelochkov@nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carrillo</surname>
            <given-names>Nuria</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="propionic-a.Tc.aff1"/>
          <email>carrilln@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Venditti</surname>
            <given-names>Charles</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="propionic-a.Tc.aff1"/>
          <email>venditti@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <aff id="propionic-a.Tc.aff1">National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
      <pub-history>
        <date date-type="created">
          <day>17</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pomc-def" document-type="chapter">Proopiomelanocortin Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="proteus" document-type="chapter">Proteus Syndrome</related-object>
      <abstract id="propionic-a.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The spectrum of propionic acidemia (PA) ranges from neonatal-onset to late-onset disease.</p>
          <list list-type="bullet">
            <list-item>
              <p>Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor feeding and decreased arousal in the first few days of life, followed by progressive encephalopathy of unexplained origin. Without prompt diagnosis and management, this is followed by progressive encephalopathy manifesting as lethargy, seizures, or coma that can result in death. It is frequently accompanied by metabolic acidosis with anion gap, lactic acidosis, ketonuria, hypoglycemia, hyperammonemia, and cytopenias.</p>
            </list-item>
            <list-item>
              <p>Individuals with late-onset PA may remain asymptomatic and suffer a metabolic crisis under catabolic stress (e.g., illness, surgery, fasting) or may experience a more insidious onset with the development of multiorgan complications including vomiting, protein intolerance, failure to thrive, hypotonia, developmental delays or regression, movement disorders, or cardiomyopathy.</p>
            </list-item>
            <list-item>
              <p>Isolated cardiomyopathy can be observed on rare occasion in the absence of clinical metabolic decompensation or neurocognitive deficits<italic toggle="yes">.</italic></p>
            </list-item>
          </list>
          <p>Manifestations of neonatal and late-onset PA over time can include growth impairment, intellectual disability, seizures, basal ganglia lesions, pancreatitis, and cardiomyopathy. Other rarely reported complications include optic atrophy, hearing loss, premature ovarian insufficiency, and chronic renal failure.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>PA is caused by deficiency of propionyl-CoA carboxylase (PCC), the enzyme that catalyzes the conversion of propionyl-CoA to methylmalonyl-CoA. Newborns with PA tested by expanded newborn screening have elevated C3 (propionylcarnitine). Testing of urine organic acids in persons who are symptomatic or those detected by newborn screening reveals elevated 3-hydroxypropionate and the presence of methylcitrate, tiglylglycine, propionylglycine, and lactic acid. Testing of plasma amino acids reveals elevated glycine. Confirmation of the diagnosis relies on detection of biallelic pathogenic variants in <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> or of deficient PCC enzymatic activity. In individuals with equivocal molecular genetic test results, a combination of enzymatic and molecular diagnostics may be necessary.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The treatment of individuals with acutely decompensated PA is a medical emergency: treat precipitating factors such as infection, dehydration, vomiting; reverse catabolism by providing intravenous glucose and lipids; manage protein intake to reduce propiogenic precursors; remove toxic compounds using nitrogen scavenger medications, extracorporeal detoxification, and/or intravenous carnitine; transfer to a center with biochemical genetics expertise and the ability to support urgent hemodialysis, especially if hyperammonemia is present.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Individualized dietary management should be directed by an experienced physician and metabolic dietician to control the intake of propiogenic substrates and to guide increased caloric intake during illness to prevent catabolism. G-tube placement is an effective strategy to facilitate the administration of medications and nutrition during acute decompensations and to improve adherence in chronic management of PA.</p>
          <p>Medications may include: L-carnitine supplementation to enhance excretion of propionic acid and oral metronidazole to reduce propionate production by gut bacteria. Orthotopic liver transplantation (OLT) may be indicated in those with frequent metabolic decompensations, uncontrollable hyperammonemia, and/or poor growth.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Consistent evaluation of the protein intake, depending on age, gender, severity of disorder and presence of other factors such as intercurrent illness, surgery, level of physical activity, and growth spurts to avoid insufficient or excessive protein restriction. Excessive protein restriction can result in deficiency of essential amino acids and impaired growth, as well as catabolism-induced metabolic decompensation.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitor closely patients with a catabolic stressor (fasting, fever, illness, injury, and surgery) to prevent and/or detect and manage metabolic decompensations early. Regularly assess: (1) growth, nutritional status, feeding ability, psychomotor development; (2) vision and hearing (3) cardiac function for signs of cardiomyopathy; (4) metabolic status by monitoring urine organic acids and plasma amino acids; (5) complete blood count; (6) renal function.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Prolonged fasting, catabolic stressors, and excessive protein intake. Lactated Ringer&#x02019;s solution is not recommended in patients with organic acidemias. In patients with QT abnormalities, avoid medications that can prolong the QT interval. Neuroleptic antiemetics (e.g., promethazine) can mask symptoms of progressive encephalopathy and are best avoided.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Testing of at-risk sibs of a patient is warranted to allow for early diagnosis and treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Propionic acidemia is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="propionic-a.Diagnosis">
        <title>Diagnosis</title>
        <p>Propionic acidemia (PA) is caused by deficiency of the mitochondrial multimeric enzyme propionyl-CoA carboxylase that catalyzes the conversion of propionyl-CoA to D-methylmalonyl-CoA. The enzyme is composed of &#x003b1;- and &#x003b2;-subunits encoded by their respective genes, <italic toggle="yes">PCCA</italic> and <italic toggle="yes">PCCB</italic>. Deficient activity of propionyl-CoA carboxylase results in accumulation of propionic acid and propionyl-CoA related metabolites, which can be detected biochemically. In many countries, infants at risk for PA can be detected via newborn screening (NBS), although symptoms may be evident in the infant before NBS results are available. Clinical manifestations of PA are often nonspecific and age of onset is variable.</p>
        <sec id="propionic-a.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Propionic acidemia (PA) <bold>should be suspected</bold> in individuals with any of the following presentations.</p>
          <p><bold>Neonatal-onset propionic acidemia (PA)</bold> is the most common clinical form of PA. In the first few days of life, infants present with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Lethargy</p>
            </list-item>
            <list-item>
              <p>Poor feeding</p>
            </list-item>
            <list-item>
              <p>Vomiting</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
          </list>
          <p>Without treatment, this can progress to encephalopathy and cardiorespiratory failure.</p>
          <p>Symptoms may be evident in the infant before NBS results are available.</p>
          <p><bold>Late-onset PA</bold> can present with a variety of concerns [<xref ref-type="bibr" rid="propionic-a.REF.delgado.2007.1405">Delgado et al 2007</xref>] including:</p>
          <list list-type="bullet">
            <list-item>
              <p>Developmental delay</p>
            </list-item>
            <list-item>
              <p>Intellectual disability</p>
            </list-item>
            <list-item>
              <p>Failure to thrive</p>
            </list-item>
            <list-item>
              <p>Chronic gastrointestinal complaints</p>
            </list-item>
            <list-item>
              <p>Protein intolerance</p>
            </list-item>
            <list-item>
              <p>Acute psychosis</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Movement disorders such as dystonia and choreoathetosis</p>
            </list-item>
          </list>
          <p>Acute decompensation can be precipitated by metabolic stressors including infection, injury, or surgery.</p>
          <p>Cardiomyopathy can occur as an apparently isolated clinical phenomenon in previously healthy individuals without documented episodes of metabolic decompensation or neurocognitive deficits [<xref ref-type="bibr" rid="propionic-a.REF.lee.2009.s97">Lee et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.laemmle.2014.971">Laemmle et al 2014</xref>].</p>
          <sec id="propionic-a.Testing">
            <title>Testing</title>
            <p><bold>Newborn screening (NBS).</bold> Detection of PA in the neonatal period is possible using acylcarnitine analysis by tandem mass spectrometry (MS/MS) on dried blood spots.</p>
            <list list-type="bullet">
              <list-item>
                <p>Acylcarnitine analysis reveals elevated propionylcarnitine (C3).</p>
              </list-item>
              <list-item>
                <p>Secondary markers including methionine, C3/C2, and C3/C16 ratios can be helpful to increase diagnostic accuracy [<xref ref-type="bibr" rid="propionic-a.REF.couce.2011.470">Couce et al 2011</xref>].</p>
              </list-item>
            </list>
            <p><bold>Biochemical analysis.</bold> Deficiency of propionyl-CoA carboxylase results in accumulation of propionic acid and propionyl-CoA related metabolites in plasma and urine, causing a wide range of laboratory test abnormalities (<xref ref-type="fig" rid="propionic-a.F1">Figure 1</xref>).</p>
            <p>Biochemical findings in propionic acidemia include:</p>
            <list list-type="bullet">
              <list-item>
                <p>Plasma acylcarnitine profile: elevated propionylcarnitine (C3)</p>
              </list-item>
              <list-item>
                <p>Urine organic acids:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Elevated 3-hydroxypropionate</p>
                  </list-item>
                  <list-item>
                    <p>Presence of:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p>Methylcitrate</p>
                      </list-item>
                      <list-item>
                        <p>Tiglylglycine</p>
                      </list-item>
                      <list-item>
                        <p>Propionylglycine</p>
                      </list-item>
                      <list-item>
                        <p>Lactic acid</p>
                      </list-item>
                    </list>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Plasma amino acids: elevated glycine</p>
              </list-item>
            </list>
            <p>Common laboratory abnormalities during acute decompensation include:</p>
            <list list-type="bullet">
              <list-item>
                <p>High-anion gap metabolic acidosis</p>
              </list-item>
              <list-item>
                <p>Lactic acidosis</p>
              </list-item>
              <list-item>
                <p>Elevated plasma and urinary ketones</p>
              </list-item>
              <list-item>
                <p>Low to normal blood glucose concentration</p>
              </list-item>
              <list-item>
                <p>Hyperammonemia</p>
              </list-item>
              <list-item>
                <p>Neutropenia, anemia, and thrombocytopenia</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="propionic-a.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>In a proband who has the clinical, laboratory, and biochemical findings reviewed <xref ref-type="sec" rid="propionic-a.Suggestive_Findings">above</xref> and in <xref ref-type="fig" rid="propionic-a.F2">Figure 2</xref>, the diagnosis of PA <bold>is established</bold> using the following strategies.</p>
          <p><bold>I. Identification of biallelic pathogenic variants in <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic></bold> on molecular genetic testing (see <xref ref-type="table" rid="propionic-a.T.summary_of_molecular_genet">Table 1</xref>). Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene testing</bold> can be considered if (1) mutation of a particular gene accounts for a large proportion of the condition <bold>or</bold> (2) factors such as clinical findings, laboratory findings, and ancestry indicate that mutation of a particular gene is most likely.</p>
              <p>For PA, neither gene is more common and there are no characteristic findings to distinguish between <italic toggle="yes">PCCA</italic>- and <italic toggle="yes">PCCB</italic>-associated PA.</p>
              <p>In instances where this testing approach is the only one available, sequence analysis of either <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">PCCA</italic> and <italic toggle="yes">PCCB</italic> and other genes of interest (see <xref ref-type="sec" rid="propionic-a.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">PCCA</italic> and <italic toggle="yes">PCCB</italic>) fails to confirm a diagnosis in an individual with features of propionic acidemia. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For issues to consider in interpretation of genomic test results, click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="propionic-a.T.summary_of_molecular_genet" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Propionic Acidemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_2">Proportion of PA Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3" id="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3" id="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PCCA</italic>
                  </td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3 hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">78%</td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3 hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">18%&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PCCB</italic>
                  </td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3 hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">97%</td>
                  <td headers="hd_h_propionic-a.T.summary_of_molecular_genet_1_1_1_3 hd_h_propionic-a.T.summary_of_molecular_genet_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3%&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="propionic-a.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="propionic-a" object-id="propionic-a.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="propionic-a.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="propionic-a.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="propionic-a.TF.1.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="propionic-a.REF.kraus.2012.51">Kraus et al [2012]</xref> reported no identifiable pathogenic variants in 7% (4/54) and one identifiable variant in 4% (2/54) of individuals with propionic acidemia. Some of the variants may have escaped detection by existing sequencing methods, but could have been detected by copy number analysis [<xref ref-type="bibr" rid="propionic-a.REF.kraus.2012.51">Kraus et al 2012</xref>]. <xref ref-type="bibr" rid="propionic-a.REF.desviat.2009.171">Desviat et al [2009]</xref> reported that only 1.5% of individuals with <italic toggle="yes">PCCA</italic>-related PA could not be characterized molecularly, when analyzed using both sequencing and copy number analysis [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2009.171">Desviat et al 2009</xref>].</p>
              </fn>
              <fn id="propionic-a.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="propionic-a.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single exon deletions or duplications.</p>
              </fn>
              <fn id="propionic-a.TF.1.6">
                <label>6. </label>
                <p>Exon deletions account for to ~20% of <italic toggle="yes">PCCA</italic> disease-causing alleles [<xref ref-type="bibr" rid="propionic-a.REF.yang.2004.335">Yang et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kaya.2008.558">Kaya et al 2008</xref>, <xref ref-type="bibr" rid="propionic-a.REF.desviat.2009.171">Desviat et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.aradhya.2012.594">Aradhya et al 2012</xref>].</p>
              </fn>
              <fn id="propionic-a.TF.1.7">
                <label>7. </label>
                <p>Three <italic toggle="yes">PCCB</italic> large-deletion alleles have been described [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2006.992">Desviat et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kraus.2012.51">Kraus et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.chiu.2014.415">Chiu et al 2014</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>II. An alternative approach involves the assay of propionyl-CoA carboxylase (PCC) enzyme activity</bold> in lymphocytes or cultured skin fibroblasts followed by molecular diagnosis [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. In individuals with equivocal molecular genetic test results, a combination of enzymatic and molecular diagnostics may be necessary.</p>
        </sec>
      </sec>
      <sec id="propionic-a.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="propionic-a.Clinical_Description">
          <title>Clinical Description</title>
          <p>Propionic acidemia presents with a wide spectrum of symptoms and age of onset. The onset of symptoms in PA varies depending on several factors including residual enzymatic activity, intake of propiogenic precursors, and the occurrence of catabolic stressors. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="propionic-a-Table3a.pdf" content-type="local-data">Table 3a</inline-supplementary-material> (pdf) and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="propionic-a-Table3b.pdf" content-type="local-data">Table 3b</inline-supplementary-material> (pdf) for a summary of major clinical findings in propionic acidemia (PA) and the reported frequency of symptoms.</p>
          <p><bold>Perinatal course.</bold> Reported maternal prenatal course, gestational age, and birth length, weight, and head circumference are similar to what is reported for unaffected infants [<xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015a.1155">K&#x000f6;lker et al 2015a</xref>]. Increased frequency of miscarriages of affected fetuses is possible [<xref ref-type="bibr" rid="propionic-a.REF.ottolenghi.2010.43">Ottolenghi et al 2010</xref>].</p>
          <p><bold>Neonatal onset PA.</bold> A typical presentation of PA in the neonatal period is characterized by a healthy newborn with poor feeding and decreased arousal in the first few days of life, followed by progressive encephalopathy of unexplained origin. Without prompt diagnosis and management, neonates can develop progressive encephalopathy manifesting as lethargy, seizures, or coma that can result in death (see <xref ref-type="table" rid="propionic-a.T.features_of_neonatalonset">Table 2</xref>). Most individuals eventually diagnosed with PA become symptomatic in the first weeks of life, with 50%-60% exhibiting clinical signs at the time of the newborn screen report [<xref ref-type="bibr" rid="propionic-a.REF.surtees.1992.333">Surtees et al 1992</xref>, <xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>].</p>
          <table-wrap id="propionic-a.T.features_of_neonatalonset" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Features of Neonatal-Onset Propionic Acidemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_propionic-a.T.features_of_neonatalonset_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Features</th>
                  <th id="hd_h_propionic-a.T.features_of_neonatalonset_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Laboratory Findings</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_propionic-a.T.features_of_neonatalonset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Poor feeding<break/>Vomiting<break/>Irritability<break/>Lethargy<break/>Progressive encephalopathy<break/>Seizures<break/>Coma<break/>Respiratory failure</td>
                  <td headers="hd_h_propionic-a.T.features_of_neonatalonset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">High anion-gap metabolic acidosis<break/>Ketonuria<break/>Hyperammonemia (&#x0003e;90%)<break/>Hypoglycemia<break/>Elevated 3-OH propionic acid &#x00026; methylcitric acid<break/>Hyperglycinemia<break/>Elevated propionylcarnitine<break/>Anemia<break/>Leukopenia<break/>Thrombocytopenia</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="propionic-a-Table3a.pdf" content-type="local-data">Table 3a</inline-supplementary-material> for a summary of the prevalence of major clinical findings during metabolic crisis in propionic acidemia.</p>
          <p>Following initial clinical and biochemical stabilization, individuals with neonatal-onset PA may develop a range of symptoms affecting different organ systems. See following and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="propionic-a-Table3b.pdf" content-type="local-data">Table 3b</inline-supplementary-material>.</p>
          <p><bold>Late-onset PA.</bold> Residual activity of propionyl-CoA carboxylase may delay the onset of symptoms beyond the neonatal period.</p>
          <p>Individuals with late-onset PA may remain asymptomatic and suffer a metabolic crisis under catabolic stress (e.g., illness, surgery, fasting) or experience a more insidious onset with the development of multiorgan complications as summarized in <xref ref-type="table" rid="propionic-a.T.features_of_lateonset_prop">Table 4</xref>. See also <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="propionic-a-Table3b.pdf" content-type="local-data">Table 3b</inline-supplementary-material>.</p>
          <table-wrap id="propionic-a.T.features_of_lateonset_prop" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Features of Late-Onset Propionic Acidemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_propionic-a.T.features_of_lateonset_prop_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Features</th>
                  <th id="hd_h_propionic-a.T.features_of_lateonset_prop_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Laboratory Findings</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_propionic-a.T.features_of_lateonset_prop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Encephalopathy, coma, and/or seizures precipitated by catabolic stressors (e.g., intercurrent illness, surgery)</p></list-item><list-item><p>Vomiting, protein intolerance, failure to thrive, hypotonia, developmental regression, movement disorders</p></list-item><list-item><p>Isolated cardiomyopathy&#x000a0;<sup>1</sup></p></list-item></list>
</td>
                  <td headers="hd_h_propionic-a.T.features_of_lateonset_prop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>&#x000b1; metabolic acidosis or hyperammonemia</p></list-item><list-item><p>Elevated 3-OH propionic acid &#x00026; methylcitric acid</p></list-item><list-item><p>Hyperglycinemia</p></list-item><list-item><p>MRI abnormalities including basal ganglia lesions&#x000a0;<sup>2</sup></p></list-item></list>
</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="propionic-a.TF.4.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="propionic-a.REF.lee.2009.s97">Lee et al [2009]</xref>
                </p>
              </fn>
              <fn id="propionic-a.TF.4.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="propionic-a.REF.broomfield.2010.256">Broomfield et al [2010]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Metabolic decompensations.</bold> Children with PA can develop episodic metabolic decompensations, especially in the first years of life. Acidosis, hyperammonemia, pancreatitis, metabolic stroke, cardiomyopathy, bone marrow suppression, seizures, and encephalopathy can accompany acutely deranged metabolism. These episodes can be life-threatening and are often precipitated by illnesses, infections, surgery, or any stress augmenting catabolism. Infectious complications (e.g., sepsis or bacterial meningitis) often accompany metabolic crises and are the major contributors to mortality [<xref ref-type="bibr" rid="propionic-a.REF.rousson.1984.10">Rousson &#x00026; Guibaud 1984</xref>, <xref ref-type="bibr" rid="propionic-a.REF.north.1995.916">North et al 1995</xref>]. The long-term cognitive outcome of individuals with PA is negatively correlated to the number of metabolic decompensations [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>].</p>
          <p><bold>Growth.</bold> Linear growth delay and deceleration of the head circumference may become evident with age and can be seen in both earlier- and late-onset groups [<xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>]. Failure to thrive may be exacerbated by malnutrition secondary to feeding difficulties, recurrent emesis, excessive protein restriction and potentially iatrogenic amino acid imbalances [<xref ref-type="bibr" rid="propionic-a.REF.manoli.2016.386">Manoli et al 2016</xref>].</p>
          <p><bold>Neurologic manifestations</bold> include developmental delay, developmental regression, intellectual disability, seizures, hypotonia, spasticity, and movement disorders [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.nizon.2013.148">Nizon et al 2013</xref>]. Developmental delays and neurologic dysfunction can be seen even in individuals without documented episodes of hyperammonemia or ketoacidosis [<xref ref-type="bibr" rid="propionic-a.REF.north.1995.916">North et al 1995</xref>, <xref ref-type="bibr" rid="propionic-a.REF.nyhan.1999.1143">Nyhan et al 1999</xref>, <xref ref-type="bibr" rid="propionic-a.REF.schreiber.2012.10">Schreiber et al 2012</xref>]. The prevalence of intellectual disability can vary between approximately 35% and 76% depending on the reported cohort [<xref ref-type="bibr" rid="propionic-a.REF.de_baulny.2005.415">de Baulny et al 2005</xref>, <xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.touati.2006.288">Touati et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Seizures</bold> were reported in 13%-53% and EEG abnormalities in 40%-63% of Individuals with PA. Reported forms of seizures included infantile spasms, tonic-clonic, tonic, myoclonic, atonic, absence, and focal [<xref ref-type="bibr" rid="propionic-a.REF.haberlandt.2009.120">Haberlandt et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.schreiber.2012.10">Schreiber et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.karimzadeh.2014.58">Karimzadeh et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>]. Seizures were one of the presenting features of the initial metabolic episode in 12%-26% of cases [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015a.1155">K&#x000f6;lker et al 2015a</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Basal ganglia changes.</bold> Individuals with PA are predisposed to basal ganglia lesions, especially during episodes of acute encephalopathy or metabolic instability [<xref ref-type="bibr" rid="propionic-a.REF.broomfield.2010.256">Broomfield et al 2010</xref>]. Basal ganglia changes seen in 7%-56% of individuals may be preceded by an acute &#x0201c;stroke-like&#x0201d; episode and manifest as altered mental status, dystonia, choreoathetosis, or hemiplegia [<xref ref-type="bibr" rid="propionic-a.REF.de_baulny.2005.415">de Baulny et al 2005</xref>, <xref ref-type="bibr" rid="propionic-a.REF.schollb_rgi.2009.76">Scholl-B&#x000fc;rgi et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.nizon.2013.148">Nizon et al 2013</xref>, <xref ref-type="bibr" rid="propionic-a.REF.karimzadeh.2014.58">Karimzadeh et al 2014</xref>]. The frequency of movement disorders in PA appears to be independent of the age of symptom onset [<xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015a.1155">K&#x000f6;lker et al 2015a</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Psychiatric manifestations.</bold> The prevalence of other comorbidities such as attention deficit disorder, autism spectrum disorder, anxiety, and acute psychosis is incompletely characterized [<xref ref-type="bibr" rid="propionic-a.REF.de_baulny.2005.415">de Baulny et al 2005</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.nizon.2013.148">Nizon et al 2013</xref>, <xref ref-type="bibr" rid="propionic-a.REF.vernon.2014.5">Vernon et al 2014</xref>]. Acute psychosis can be a presenting feature of PA in older individuals, especially in those not evaluated by newborn screen, thus warranting a high index of suspicion for this uncommon cause of psychosis in the general population [<xref ref-type="bibr" rid="propionic-a.REF.shuaib.2012.799">Shuaib et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.nizon.2013.148">Nizon et al 2013</xref>, <xref ref-type="bibr" rid="propionic-a.REF.dejean_de_la_b_tie.2014.274">Dejean de la B&#x000e2;tie et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Brain MRI findings</bold> include delayed myelination, white matter changes, basal ganglia abnormalities, cerebellar hemorrhage, and cerebral atrophy [<xref ref-type="bibr" rid="propionic-a.REF.schreiber.2012.10">Schreiber et al 2012</xref>]. Clinically unstable individuals appear to be at higher risk of developing brain abnormalities. In a study of 17 PA individuals with clinical seizures, all had abnormal MRI findings and a history of more than ten metabolic decompensations [<xref ref-type="bibr" rid="propionic-a.REF.haberlandt.2009.120">Haberlandt et al 2009</xref>]. Magnetic resonance spectroscopy (MRS) can reveal decreased myoinositol, N-acetylaspartate and elevated Glx (glutamine, glutamate, and gamma-aminobutyric acid) peaks in basal ganglia [<xref ref-type="bibr" rid="propionic-a.REF.bergman.1996.404">Bergman et al 1996</xref>].</p>
            </list-item>
          </list>
          <p><bold>Cardiomyopathy</bold> has been recognized as a common complication of PA. Both dilated and hypertrophic cardiomyopathy have been reported [<xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>]. In the period between 2000 and 2015, its reported prevalence varied between 7% and 24% in various PA cohorts [<xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Early clinical manifestations of cardiomyopathy include tachypnea, hepatomegaly, hypotension, tachycardia, or bradycardia.</p>
            </list-item>
            <list-item>
              <p>The mean age of onset of cardiomyopathy was seven years in a study by <xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al [2010]</xref>.</p>
            </list-item>
            <list-item>
              <p>The age of PA diagnosis, frequency of metabolic decompensation, and residual enzymatic activity do not correlate with presence/absence of cardiomyopathy in individuals with PA [<xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Rarely, cardiomyopathy can occur as an apparently isolated clinical phenomenon in previously healthy individuals without documented episodes of metabolic decompensation or neurocognitive deficits [<xref ref-type="bibr" rid="propionic-a.REF.lee.2009.s97">Lee et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.laemmle.2014.971">Laemmle et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Cardiomyopathy can progress to cardiac failure and may be associated with sudden death [<xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Cardiac rhythm abnormalities.</bold> A prolonged QT interval is often detected in individuals with PA [<xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>]. This can be associated with syncope, arrhythmia, and cardiac arrest [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2007.192">Baumgartner et al 2007</xref>, <xref ref-type="bibr" rid="propionic-a.REF.jameson.2008.969">Jameson &#x00026; Walter 2008</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>].</p>
          <p>
            <bold>Gastrointestinal manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Pancreatitis (reported in 3%-18% of individuals) may be recurrent and may present with anorexia, recurrent nausea, and abdominal pain [<xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>]. In some individuals recurrent pancreatitis can lead to insulin-dependent diabetes.</p>
            </list-item>
            <list-item>
              <p>Poor feeding and lack of appetite are common, affecting up to 76% of affected individuals [<xref ref-type="bibr" rid="propionic-a.REF.touati.2006.288">Touati et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Emesis and diarrhea are commonly reported in individuals with PA, becoming a recurrent problem in approximately 6% [<xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>].</p>
            </list-item>
            <list-item>
              <p>Liver issues include hepatomegaly, hypoalbuminemia, and abnormal liver function tests (ALT, AST, GGT, INR, and bilirubin) [<xref ref-type="bibr" rid="propionic-a.REF.karimzadeh.2014.58">Karimzadeh et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>]. The etiology of hepatic dysfunction has not been determined with certainty but may include the inherent metabolic derangement as well as cardiac dysfunction in individuals with cardiomyopathy.</p>
            </list-item>
          </list>
          <p><bold>Renal abnormalities</bold> have been infrequently documented and are likely underreported. Examples have included impaired renal function [<xref ref-type="bibr" rid="propionic-a.REF.lehnert.1994.s68">Lehnert et al 1994</xref>], chronic renal insufficiency leading to renal transplant at age 42 years [<xref ref-type="bibr" rid="propionic-a.REF.lam.2011.338">Lam et al 2011</xref>], and progressive kidney disease in the third decade of life [<xref ref-type="bibr" rid="propionic-a.REF.vernon.2014.5">Vernon et al 2014</xref>].</p>
          <p><bold>Hematologic abnormalities.</bold> Although anemia, leukopenia, and thrombocytopenia are common, pancytopenia is seen less frequently, in 6%-15% of individuals [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.karimzadeh.2014.58">Karimzadeh et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>]. Myelodysplastic changes in the bone marrow are uncommon [<xref ref-type="bibr" rid="propionic-a.REF.stork.1986.783">Stork et al 1986</xref>, <xref ref-type="bibr" rid="propionic-a.REF.sipahi.2004.154">Sipahi et al 2004</xref>].</p>
          <p><bold>Immune system.</bold> Early retrospective data suggested high frequency of recurrent infections seen in 60%-80% of affected individuals [<xref ref-type="bibr" rid="propionic-a.REF.lehnert.1994.s68">Lehnert et al 1994</xref>, <xref ref-type="bibr" rid="propionic-a.REF.al_essa.1998.90">Al Essa et al 1998</xref>]. Factors predisposing to infectious complications were likely diverse and included bone marrow suppression, immune dysfunction instigated by propionic acid metabolites, indwelling catheters (e.g., central lines), frequent hospitalizations, and potential nutritional deficiencies caused by dietary modification. Although staphylococcal scalded skin syndrome and <italic toggle="yes">Candida</italic> skin infections were reported in the earlier literature [<xref ref-type="bibr" rid="propionic-a.REF.lehnert.1994.s68">Lehnert et al 1994</xref>, <xref ref-type="bibr" rid="propionic-a.REF.al_essa.1998.90">Al Essa et al 1998</xref>], more recent natural history studies suggest that such complications are uncommon [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>].</p>
          <p>Hypogammaglobulinemia, B-cell lymphopenia, decreased CD4 and CD8 counts, and abnormal CD4/CD8 ratio have been described [<xref ref-type="bibr" rid="propionic-a.REF.m_ller.1980.551">M&#x000fc;ller et al 1980</xref>, <xref ref-type="bibr" rid="propionic-a.REF.griffin.1996.875">Griffin et al 1996</xref>, <xref ref-type="bibr" rid="propionic-a.REF.al_essa.1998.90">Al Essa et al 1998</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>]. Hypogammaglobulinemia, reported in as many as 15% of affected individuals, has required treatment with immunoglobulin in some cases [<xref ref-type="bibr" rid="propionic-a.REF.m_ller.1980.551">M&#x000fc;ller et al 1980</xref>, <xref ref-type="bibr" rid="propionic-a.REF.raby.1994.250">Raby et al 1994</xref>, <xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>].</p>
          <p><bold>Ophthalmologic</bold>
<bold>manifestations.</bold> Eye findings include dyschromatopsia, optic atrophy, scotomas, abnormal electroretinogram, visual evoked potentials, and optical coherent tomography. In addition, optic tract and cortical abnormalities have been occasionally noted [<xref ref-type="bibr" rid="propionic-a.REF.noval.2013.90">Noval et al 2013</xref>, <xref ref-type="bibr" rid="propionic-a.REF.arias.2014.1">Arias et al 2014</xref>].</p>
          <p>Optic neuropathy occurs in 11%-25% [<xref ref-type="bibr" rid="propionic-a.REF.pena.2012.1641">Pena &#x00026; Burton 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>]. The onset of optic neuropathy can be acute or insidious; further deterioration can occur during metabolic decompensations triggered by infections or surgery [<xref ref-type="bibr" rid="propionic-a.REF.noval.2013.90">Noval et al 2013</xref>, <xref ref-type="bibr" rid="propionic-a.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>]. The mean age of diagnosis is approximately 13 years (range 2-24 years) [<xref ref-type="bibr" rid="propionic-a.REF.arias.2014.1">Arias et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>].</p>
          <p><bold>Hearing loss.</bold> Sensorineural hearing loss was reported in 1% and 13% in two large cohorts of individuals with PA [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>].</p>
          <p><bold>Musculoskeletal system.</bold> Severe osteopenia and osteoporosis have been described in adults with PA [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>].</p>
          <p><bold>Dermatologic manifestations</bold> resembling acrodermatitis enteropathica are frequently associated with deficiency of essential amino acids, particularly isoleucine, which can be inadvertently over-restricted in the diet of persons with PA [<xref ref-type="bibr" rid="propionic-a.REF.dom_nguezcruz.2011.115">Dom&#x000ed;nguez-Cruz et al 2011</xref>].</p>
          <p><bold>Other rare complications.</bold>
Isolated case reports describe clinical findings that could be causally associated with propionic acidemia, but require further characterization: muscle lipidosis [<xref ref-type="bibr" rid="propionic-a.REF.de_baulny.2005.415">de Baulny et al 2005</xref>]; myopathy [<xref ref-type="bibr" rid="propionic-a.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>]; premature ovarian insufficiency [<xref ref-type="bibr" rid="propionic-a.REF.lam.2011.338">Lam et al 2011</xref>]; oligomenorrhea [<xref ref-type="bibr" rid="propionic-a.REF.mart_nhern_ndez.2009.523">Mart&#x000ed;n-Hern&#x000e1;ndez et al 2009</xref>]; hypothyroidism [<xref ref-type="bibr" rid="propionic-a.REF.vernon.2014.5">Vernon et al 2014</xref>, <xref ref-type="bibr" rid="propionic-a.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>]; parathyroid hormone resistance resolving after hemodialysis [<xref ref-type="bibr" rid="propionic-a.REF.griffin.1996.875">Griffin et al 1996</xref>].</p>
          <p><bold>Life span.</bold> PA confers a high risk of mortality. Reported mortality rates appear to be on the decline: 41%-90% in the 1980-90s, 17%-72% in 2000s, and 7%-12% in early 2010s [<xref ref-type="bibr" rid="propionic-a.REF.rousson.1984.10">Rousson &#x00026; Guibaud 1984</xref>, <xref ref-type="bibr" rid="propionic-a.REF.surtees.1992.333">Surtees et al 1992</xref>, <xref ref-type="bibr" rid="propionic-a.REF.van_der_meer.1996.205">van der Meer et al 1996</xref>, <xref ref-type="bibr" rid="propionic-a.REF.p_rezcerd_.2000.187">P&#x000e9;rez-Cerd&#x000e1; et al 2000</xref>, <xref ref-type="bibr" rid="propionic-a.REF.sass.2004.837">Sass et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.de_baulny.2005.415">de Baulny et al 2005</xref>, <xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.touati.2006.288">Touati et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>]. Observed decline in reported mortality likely reflects the length of follow up, introduction of newborn screening, expansion of the PA phenotype, proactive medical management, and elective liver transplantation.</p>
          <p><bold>Long-term adult outcomes.</bold> Systematic studies of adult individuals with PA are lacking. Early reports suggest that adults with PA can experience significant osteopenia, osteoporosis, renal failure, and premature ovarian failure [<xref ref-type="bibr" rid="propionic-a.REF.mart_nhern_ndez.2009.523">Mart&#x000ed;n-Hern&#x000e1;ndez et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.lam.2011.338">Lam et al 2011</xref>, <xref ref-type="bibr" rid="propionic-a.REF.vernon.2014.5">Vernon et al 2014</xref>].</p>
          <p><bold>Atypical presentation.</bold> Apparently asymptomatic individuals with PA (9%-17% in different cohorts) represent a heterogeneous group consisting of otherwise healthy infants identified after newborn screening, sibs ascertained through evaluation prompted by diagnosis of the proband, and individuals with a diagnosis of PA with incomplete clinical characterization [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.k_lker.2015a.1155">K&#x000f6;lker et al 2015a</xref>].</p>
        </sec>
        <sec id="propionic-a.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>Although precise genotype-phenotype correlations do not exist, some general comments related to molecular genetics are relevant.</p>
          <list list-type="bullet">
            <list-item>
              <p>Null variants (<italic toggle="yes">PCCA</italic>: <xref ref-type="table" rid="propionic-a.T.selected_pcca_pathogenic_v">p.Arg313Ter</xref>, <xref ref-type="table" rid="propionic-a.T.selected_pcca_pathogenic_v">p.Ser562Ter</xref>; <italic toggle="yes">PCCB</italic>: p.Gly406fs, <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Gly94Ter</xref>, and out-of-frame small deletions/insertions, genomic abnormalities) result in loss-of-function alleles and are associated with a more severe form of PA [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.desviat.2009.171">Desviat et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Homozygous missense pathogenic variants, in which partial enzymatic activity is retained (<italic toggle="yes">PCCA</italic>: <xref ref-type="table" rid="propionic-a.T.selected_pcca_pathogenic_v">p.Ala138Thr</xref>, <xref ref-type="table" rid="propionic-a.T.selected_pcca_pathogenic_v">p.Ile164Thr</xref>, <xref ref-type="table" rid="propionic-a.T.selected_pcca_pathogenic_v">p.Arg288Gly</xref>; <italic toggle="yes">PCCB</italic>: <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Asn536Asp</xref>) have been associated with a less severe phenotype.</p>
            </list-item>
            <list-item>
              <p>Some missense pathogenic variants (<italic toggle="yes">PCCB</italic>
<xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Gly112Asp</xref>, <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Arg512Cys</xref>, and <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Leu519Pro</xref>) which affect heterododecamer formation can result in undetectable PCC enzyme activity and severe phenotype [<xref ref-type="bibr" rid="propionic-a.REF.muro.2001.476">Muro et al 2001</xref>].</p>
            </list-item>
          </list>
          <p>A homozygous <italic toggle="yes">PCCB</italic> variant in Amish and Mennonite populations, <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Asn536Asp</xref>, is associated with high residual PCC activity. It confers a lower risk of developing metabolic crisis, but can lead to late-onset cardiomyopathy.</p>
          <p>A homozygous <italic toggle="yes">PCCB</italic> variant, <xref ref-type="table" rid="propionic-a.T.selected_pccb_pathogenic_v">p.Tyr435Cys</xref><italic toggle="yes">,</italic> has been detected in apparently asymptomatic or mildly affected children identified through newborn screening in Japan [<xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2002.161">Yorifuji et al 2002</xref>].</p>
        </sec>
        <sec id="propionic-a.Nomenclature">
          <title>Nomenclature</title>
          <p>Propionic acidemia and propionyl-CoA carboxylase deficiency are the two most common terms used to describe the condition. Ketotic hyperglycinemia was used in the 1960s before defects in propionyl-CoA carboxylase were determined to be the underlying cause of PA [<xref ref-type="bibr" rid="propionic-a.REF.hsia.1969.757">Hsia et al 1969</xref>]. The term propionic aciduria is used infrequently.</p>
        </sec>
        <sec id="propionic-a.Prevalence">
          <title>Prevalence</title>
          <p>Worldwide, the incidence of PA varies widely. The estimated live-birth incidence of PA is 1:105,000-1:130,000 in the US [<xref ref-type="bibr" rid="propionic-a.REF.chace.2001.2040">Chace et al 2001</xref>, <xref ref-type="bibr" rid="propionic-a.REF.couce.2011.470">Couce et al 2011</xref>], 1:166,000 in Italy [<xref ref-type="bibr" rid="propionic-a.REF.dionisivici.2002.321">Dionisi-Vici et al 2002</xref>] and 1:250,000 in Germany [<xref ref-type="bibr" rid="propionic-a.REF.schulze.2003.1399">Schulze et al 2003</xref>].</p>
          <p>The incidence appears to be higher in the Middle East. In the United Arab Emirates, the birth incidence of PA is ~1:20,000-1:45,000 [<xref ref-type="bibr" rid="propionic-a.REF.alshamsi.2014.e42">Al-Shamsi et al 2014</xref>]. In Saudi Arabia the birth incidence is 1:28,000 [<xref ref-type="bibr" rid="propionic-a.REF.rashed.2001.27">Rashed 2001</xref>], and can be higher in some Saudi tribes: 1:2000-1:5000 [<xref ref-type="bibr" rid="propionic-a.REF.zayed.2015.119">Zayed 2015</xref>].</p>
          <p>In Japan, the live birth incidence of severe propionic acidemia is 1:465,000, but increases to 1:17,400 when combined with an apparently asymptomatic form of PA identified through newborn screening [<xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2002.161">Yorifuji et al 2002</xref>].</p>
          <p>The highest reported birth incidence is found among the Greenlandic Inuits: 1:1000 [<xref ref-type="bibr" rid="propionic-a.REF.ravn.2000.203">Ravn et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="propionic-a.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic>.</p>
      </sec>
      <sec id="propionic-a.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Elevated C3 (propionylcarnitine) on newborn screening</bold> can be caused by methylmalonic acidemias resulting from <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">methylmalonyl-CoA mutase deficiency</related-object>, disorders of <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">intracellular cobalamin metabolism</related-object> and maternal B<sub>12</sub> deficiency.</p>
        <p>The presence of elevated <bold>3-hydroxypropionic with or without methylcitric acid on</bold> the urine organic acid assay should prompt additional diagnostic considerations:</p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple carboxylase deficiency (biotinidase and holocarboxylase synthetase deficiencies), which also shows elevation of lactic acid, 3-hydroxyvaleric acid and 3-methylcrotonylglycine caused by defective activity of pyruvate carboxylase, propionyl-CoA carboxylase, and 3-methylcrotonyl-CoA carboxylase</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic acidemias</related-object>, which have elevations of 2-methylcitric acid and 3-hydroxypropionic acid, and additionally show elevations of methylmalonic acid. Cobalamin C, D, and F metabolism defects result in abnormal homocysteine metabolism. Total plasma homocysteine can help in the diagnostic workup of individuals ascertained with elevated propionylcarnitine.</p>
          </list-item>
          <list-item>
            <p>Maternal B<sub>12</sub> deficiency identified through elevated propionylcarnitine on the newborn screen can also present with elevated urinary methylmalonic acid and total plasma homocysteine in infant. In maternal vitamin B<sub>12</sub> deficiency, infant vitamin B<sub>12</sub> levels can be in the normal range [<xref ref-type="bibr" rid="propionic-a.REF.sarafoglou.2011.1198">Sarafoglou et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p>Urine organic acid assay in individuals with carbonic anhydrase VA deficiency can reveal elevated 3-hydroxypropionic acid, propionylglycine, and methylcitric acid as well as 3-methylcrotonylglycine, 3-hydroxybutyric, alpha-ketoglutaric, and 3-hydroxyisovaleric acids. Plasma acylcarnitine profile in individuals with carbonic anhydrase VA deficiency is usually normal.</p>
          </list-item>
          <list-item>
            <p>Methylmalonic semialdehyde dehydrogenase deficiency may result in accumulation of 3-hydroxyisobutyric, 3-hydroxypropionic, 3-aminoisobutyric, and methylmalonic acids [<xref ref-type="bibr" rid="propionic-a.REF.marcadier.2013.98">Marcadier et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p>Bacterial overgrowth (including <italic toggle="yes">Propionibacterium or Lactobacterium</italic>) or short gut syndrome [<xref ref-type="bibr" rid="propionic-a.REF.haan.1985.63">Haan et al 1985</xref>]</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial disorder</related-object> may enter the differential diagnosis when individuals present with hyperammonemia, metabolic acidosis, ketonuria, and hypoglycemia [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
          </list-item>
        </list>
        <p><bold>Hyperglycinemia</bold> can be seen in a wide range of clinical conditions including nonketotic hyperglycinemia, valproate treatment, ketotic hyperglycinemia, and transient glycine encephalopathy. See <related-object link-type="booklink" source-id="gene" document-id="nkh" document-type="chapter">Glycine Encephalopathy</related-object>.</p>
        <p><bold>Hyperammonemia</bold> in neonatal PA can prompt clinicians to consider other disorders affecting ammonia metabolism including <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">urea cycle disorders</related-object>, organic acidemias, <related-object link-type="booklink" source-id="gene" document-id="pdc" document-type="chapter">pyruvate carboxylase deficiency</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ca5a-def" document-type="chapter">carbonic anhydrase VA deficiency</related-object>, and porto-systemic shunts. Usually, the glutamine levels in hyperammonemic patients with PA are normal or low [<xref ref-type="bibr" rid="propionic-a.REF.alhassnan.2003.89">Al-Hassnan et al 2003</xref>, <xref ref-type="bibr" rid="propionic-a.REF.filipowicz.2006.123">Filipowicz et al 2006</xref>].</p>
        <p><bold>Increased anion-gap metabolic acidosis.</bold> Possible causes are numerous and may include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Those conditions included in the commonly used mnemonic MUDPILES: <italic toggle="yes">m</italic>ethanol, <italic toggle="yes">u</italic>remia (chronic renal failure), <italic toggle="yes">d</italic>iabetic ketoacidosis, <italic toggle="yes">p</italic>ropylene glycol, <italic toggle="yes">i</italic>nfection, <italic toggle="yes">i</italic>ron, <italic toggle="yes">i</italic>soniazid, <italic toggle="yes">l</italic>actic acidosis, <italic toggle="yes">e</italic>thylene glycol, <italic toggle="yes">s</italic>alicylates</p>
          </list-item>
          <list-item>
            <p>Organic acidemias</p>
          </list-item>
        </list>
        <p><bold>Poisoning and child abuse.</bold> In at least one individual with organic acidemia, propionic acid was misidentified as ethylene glycol [<xref ref-type="bibr" rid="propionic-a.REF.hoffman.1991.931">Hoffman 1991</xref>]. In another case, ethylene glycol poisoning presented with hyperglycinemia and glycolic acid in urine [<xref ref-type="bibr" rid="propionic-a.REF.woolf.1992.421">Woolf et al 1992</xref>].</p>
      </sec>
      <sec id="propionic-a.Management">
        <title>Management</title>
        <p>The optimal management of patients with propionic acidemia (PA) is best achieved by a team comprising a physician with metabolic expertise, a dietician, and a genetic counselor. Several proposed acute and chronic management guidelines have become available in recent years [<xref ref-type="bibr" rid="propionic-a.REF.chapman.2012.16">Chapman et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. Management of symptomatic hyperammonemic patients awaiting confirmatory testing can be particularly challenging and requires pursuit of several diagnostic considerations [<xref ref-type="bibr" rid="propionic-a.REF.h_berle.2012.32">H&#x000e4;berle et al 2012</xref>]. Also see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180313/table/Tab6/">Table 6</ext-link> in <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al [2014]</xref>.</p>
        <sec id="propionic-a.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with PA the following evaluations are recommended (see <xref ref-type="fig" rid="propionic-a.F2">Figure 2</xref>):</p>
          <list list-type="bullet">
            <list-item>
              <p>Blood gas with base balance, electrolytes with anion gap, glucose, plasma ammonia, calcium, phosphorus, urine ketones</p>
            </list-item>
            <list-item>
              <p>Plasma amino acids, total and free carnitine and acylcarnitine profile, and urine organic acid analysis</p>
            </list-item>
            <list-item>
              <p>Complete blood count to evaluate for cytopenias</p>
            </list-item>
            <list-item>
              <p>Consider initiating an evaluation for sepsis if the CBC and individual&#x02019;s clinical signs suggest that infection is likely</p>
            </list-item>
            <list-item>
              <p>Amylase and lipase to evaluate for pancreatitis</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
          <p>Once the patient becomes stable, evaluations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical assessment of growth parameters, ability to feed, the need for G-tube placement, and neurologic status.</p>
            </list-item>
            <list-item>
              <p>Laboratory assessment of nutritional status (calcium, phosphorus, albumin, prealbumin, plasma amino acids, vitamin levels [including thiamine and 25-hydroxyvitamin D], iron panel, and minerals and renal function); complete blood count to monitor for cytopenias</p>
            </list-item>
            <list-item>
              <p>Clinical evaluation for cardiomyopathy and arrhythmia with ECG, 24-hour Holter monitor, echocardiogram</p>
            </list-item>
            <list-item>
              <p>EEG and brain MRI in symptomatic individuals</p>
            </list-item>
            <list-item>
              <p>Developmental evaluation</p>
            </list-item>
            <list-item>
              <p>Dilated eye examination</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation</p>
            </list-item>
            <list-item>
              <p>Immunology consult</p>
            </list-item>
          </list>
          <p>Other</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete adherence to regional immunization schedules and influenza vaccination is indicated [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Maintain a high index of suspicion for endocrine, immune, and renal problems and address accordingly.</p>
            </list-item>
          </list>
        </sec>
        <sec id="propionic-a.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Neonatal/acute decompensation.</bold> Birth, infections, trauma, surgery, postpartum recovery, or other forms of stress and hormonal changes can result in a catabolic response that leads, among other things, to protein breakdown with release of propiogenic amino acids that cannot be metabolized in PA. The goal of acute management is to reverse this process through promotion of anabolism and removal of toxic intermediates. The treatment of individuals with acutely decompensated PA is a medical emergency and requires a transfer to a center with biochemical genetics expertise and the ability to support urgent hemodialysis, especially if hyperammonemia is present.</p>
          <p>
            <bold>In-patient management</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Assess and manage ventilation and circulation as necessary.</p>
            </list-item>
            <list-item>
              <p>Treat precipitating factors (fever, infection, dehydration, pain, vomiting, and other sources of stress).</p>
            </list-item>
            <list-item>
              <p>Determine the need for sepsis workup and antibiotics.</p>
            </list-item>
            <list-item>
              <p>Reverse catabolism by giving intravenous glucose and lipids.</p>
              <list list-type="bullet">
                <list-item>
                  <p>The volume, glucose content and electrolyte composition of intravenous fluids is determined by age, target glucose infusion rate, cardiovascular status, renal condition, and co-administration of other medications.</p>
                </list-item>
                <list-item>
                  <p>Intravenous D10 &#x000bd; normal saline typically between 100% and 150% of the maintenance requirements is a common starting fluid. Dextrose solutions exceeding the concentration of 12.5% require a central line placement. The target glucose infusion rates varies by age [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
                </list-item>
                <list-item>
                  <p>Additional calories can be provided using parenteral lipid emulsion.</p>
                </list-item>
                <list-item>
                  <p>The use of intravenous insulin drip may be needed to maintain euglycemia and promote anabolism.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Manage protein intake to reduce propiogenic precursors; avoidance of protein transiently for &#x0003c;24-36 hours may be required.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Transition to enteral feedings should be commenced as soon as they are tolerated (see <xref ref-type="sec" rid="propionic-a.Prevention_of_Primary_Manife">Prevention of Primary Manifestations</xref>, <bold>Dietary management</bold>).</p>
                </list-item>
                <list-item>
                  <p>If transition to enteral feedings within 48 hours is not possible, total parenteral nutrition is required.</p>
                </list-item>
                <list-item>
                  <p>Parenteral amino acid solutions are prescribed based on the recommended daily intake of age-appropriate energy, protein, isoleucine, valine, methionine, and threonine and adjusted using the daily and weekly growth data and plasma amino acid concentrations.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Remove toxic compounds.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Pharmacologic detoxification:</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Nitrogen scavenger medications (sodium benzoate, sodium phenylacetate, sodium phenylbutyrate), such as those used in <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">urea cycle disorders</related-object> to help control ammonia levels during acute decompensations, should be used with caution in the treatment of hyperammonemia associated with PA as they can accentuate frequently observed low plasma glutamine [<xref ref-type="bibr" rid="propionic-a.REF.alhassnan.2003.89">Al-Hassnan et al 2003</xref>, <xref ref-type="bibr" rid="propionic-a.REF.filipowicz.2006.123">Filipowicz et al 2006</xref>]. For a discussion regarding the use of sodium benzoate versus sodium phenylacetate and sodium phenylbutyrate in propionic acidemia see <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al [2014]</xref>.</p>
                    </list-item>
                    <list-item>
                      <p>Oral N-carbamoylglutamate (carglumic acid; 100 mg/kg divided every 6 hours in individuals &#x0003c;20 kg and 2.2 gm/m<sup>2</sup> in individuals &#x0003e;20 kg) can aid in the detoxification of ammonia during neonatal and acute decompensations [<xref ref-type="bibr" rid="propionic-a.REF.filippi.2010.286">Filippi et al 2010</xref>, <xref ref-type="bibr" rid="propionic-a.REF.schwahn.2010.133">Schwahn et al 2010</xref>, <xref ref-type="bibr" rid="propionic-a.REF.chapman.2012.16">Chapman et al 2012</xref>].</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p>Extracorporeal detoxification is required for persistent acidosis and hyperammonemia (plasma ammonia level &#x0003e;250-300 &#x003bc;mol/L) not responding to fluid and drug treatment. Methods include (depending on age and clinical situation) continuous veno-venous hemofiltration, extracorporeal membrane oxygenation, or hemodialysis [<xref ref-type="bibr" rid="propionic-a.REF.chapman.2012.16">Chapman et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
                </list-item>
                <list-item>
                  <p>Carnitine supplementation (100 mg/kg/day IV divided in 3 doses) may enhance the detoxification of propionic acid by conjugating into propionylcarnitine, which is excreted by the kidneys. Alternatively, it may relieve intracellular coenzyme A accretion and provide a benefit through this mechanism. Consult hospital pharmacy for the recommended maximum daily dose in older patients.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Manage pancreatitis using standard practices.</p>
            </list-item>
          </list>
          <p><bold>Home management of metabolic status.</bold> The detection and management of metabolic decompensations at home are a critical part of the chronic management of PA. Patients and care providers should notify their medical team about new symptoms and discuss the appropriateness of home management. Strategies to achieve home management should be tailored for the conditions of each patient and family and may include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>At-home detection and monitoring of urine ketones</p>
            </list-item>
            <list-item>
              <p>Diet modification under the direction of the metabolic team</p>
            </list-item>
            <list-item>
              <p>If fever is present due to an infection, treatment may include paracetamol and ibuprofen [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Use of anti-emetics such as ondansetron (see precautionary considerations in <xref ref-type="sec" rid="propionic-a.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>)</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Any injury, illness, hospitalization, or surgical procedure should involve consultation with the metabolic team.</p>
            </list-item>
            <list-item>
              <p>The diagnosis and management of pancreatitis is the same as for pancreatitis of other causes.</p>
            </list-item>
            <list-item>
              <p>Neutropenia and other cytopenias usually improve with metabolic control of PA.</p>
            </list-item>
            <list-item>
              <p>Management of arrhythmias is similar to that from other causes.</p>
            </list-item>
            <list-item>
              <p>Cardiomyopathy may improve after liver transplantation in some patients [<xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Seizures are a frequent complication of PA, necessitating an antiepileptic drug. The use of valproic acid in organic acidemias is often avoided; however, several authors described its use in patients with PA [<xref ref-type="bibr" rid="propionic-a.REF.haberlandt.2009.120">Haberlandt et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.schreiber.2012.10">Schreiber et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Dermatologic manifestations (e.g., persistent dermatitis or eczema) warrant a nutritional reassessment to rule out dietary deficiency of essential amino acids, essential fatty acids, vitamins, and minerals.</p>
            </list-item>
          </list>
        </sec>
        <sec id="propionic-a.Prevention_of_Primary_Manife">
          <title>Prevention of Primary Manifestations</title>
          <p><bold>Dietary management.</bold> The mainstay nutritional intervention is modification of diet to control the intake of propiogenic substrates (isoleucine, valine, methionine, and threonine), while ensuring normal protein synthesis and preventing protein catabolism, amino acid deficiencies, and growth restriction.</p>
          <p>Important note: Dietary management needs to be directed by an experienced physician and metabolic dietician.</p>
          <list list-type="bullet">
            <list-item>
              <p>Recommended protein intake depends on age of the patient (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180313/table/Tab11/">Table 11</ext-link> in <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al [2014]</xref>).</p>
            </list-item>
            <list-item>
              <p>The ratio of natural source protein to medical foods varies depending on the individual&#x02019;s clinical status, laboratory parameters, and growth trajectory [<xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Laboratory parameters useful in guiding nutritional intervention can include the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Pre-prandial plasma essential amino acids</p>
                </list-item>
                <list-item>
                  <p>Plasma albumin</p>
                </list-item>
                <list-item>
                  <p>Prealbumin</p>
                </list-item>
                <list-item>
                  <p>Hemoglobin</p>
                </list-item>
                <list-item>
                  <p>Plasma ammonia</p>
                </list-item>
                <list-item>
                  <p>Urinary ketones, plasma lactic acid, and methylcitric acid to monitor and adjust nutritional management</p>
                </list-item>
                <list-item>
                  <p>Plasma vitamin D</p>
                </list-item>
                <list-item>
                  <p>Essential fatty acid profile</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Additional calories can be provided using protein-free formulas.</p>
            </list-item>
            <list-item>
              <p>G-tube placement is an effective strategy to facilitate the administration of medications and nutrition during acute decompensations and to improve adherence in chronic management of PA.</p>
            </list-item>
            <list-item>
              <p>Since the number of acute decompensations negatively correlates with the intellectual quotient in patients with PA [<xref ref-type="bibr" rid="propionic-a.REF.gr_nert.2012.41">Gr&#x000fc;nert et al 2012</xref>], prevention and proactive management of metabolic crises can be an important point of intervention to maximize favorable clinical outcomes.</p>
            </list-item>
          </list>
          <p>
            <bold>Medications</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Levocarnitine.</bold> The optimal dose of levocarnitine has not been established; doses ranging from 50 to 300 mg/kg per day have been reported [<xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>When calculating the daily dose of levocarnitine, one needs to consider the presence of this pharmaceutic compound in medical foods and the maximum daily dose in older patients.</p>
                </list-item>
                <list-item>
                  <p>Levocarnitine can be given enterally and intravenously.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Antimicrobial therapy.</bold> Oral metronidazole has been shown to reduce propionic acid production by intestinal gut flora [<xref ref-type="bibr" rid="propionic-a.REF.thompson.1990.408">Thompson et al 1990</xref>, <xref ref-type="bibr" rid="propionic-a.REF.mellon.2000.169">Mellon et al 2000</xref>]. One regimen uses a one-week-on, three-weeks-off approach [<xref ref-type="bibr" rid="propionic-a.REF.chapman.2012.16">Chapman et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Biotin supplementation.</bold> There is no consensus regarding the use of biotin supplementation nor the optimal dose in the treatment of PA. Given biotin&#x02019;s favorable profile, a short therapeutic trial may be considered [<xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. Whether a biotin-responsive form of PA exists is not known [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
            </list-item>
          </list>
          <p><bold>Management during episodes of metabolic decompensation</bold> includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Avoidance of fasting (e.g., using intravenous dextrose).</p>
            </list-item>
            <list-item>
              <p>Increasing calorie intake to prevent catabolism (e.g., intravenous fat emulsion).</p>
            </list-item>
          </list>
          <p>When enteral feeding cannot be provided for a prolonged period of time, judicious use of total parenteral nutrition may include standard amino acid mixes providing age-appropriate recommended daily allowance of protein [<xref ref-type="bibr" rid="propionic-a.REF.sutton.2012.26">Sutton et al 2012</xref>]. In rare circumstances, specialized amino acid mixes with reduced content of isoleucine, valine, threonine and methionine are necessary.</p>
          <p><bold>Organ transplantation.</bold> Orthotopic liver transplantation (OLT) may be indicated in those individuals who, despite adequate medical treatment, still experience frequent metabolic decompensations, uncontrollable hyperammonemia, and poor growth [<xref ref-type="bibr" rid="propionic-a.REF.barshes.2006.773">Barshes et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.charbithenrion.2015.786">Charbit-Henrion et al 2015</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Benefits of OLT include decrease in the frequency of metabolic decompensations, improved quality-adjusted life years, increased life expectancy, life-time cost savings [<xref ref-type="bibr" rid="propionic-a.REF.vara.2011.661">Vara et al 2011</xref>, <xref ref-type="bibr" rid="propionic-a.REF.li.2015.1208">Li et al 2015</xref>], and reversal of dilated cardiomyopathy [<xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2004.205">Yorifuji et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Liver transplantation has been performed from unrelated donors [<xref ref-type="bibr" rid="propionic-a.REF.barshes.2006.773">Barshes et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.romano.2010.128">Romano et al 2010</xref>] and from heterozygous related donors [<xref ref-type="bibr" rid="propionic-a.REF.morioka.2005.2754">Morioka et al 2005</xref>, <xref ref-type="bibr" rid="propionic-a.REF.vara.2011.661">Vara et al 2011</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kasahara.2012.230">Kasahara et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Continuous hemofiltration, extracorporeal membrane oxygenation (ECMO) [<xref ref-type="bibr" rid="propionic-a.REF.sato.2009.790">Sato et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kasahara.2012.230">Kasahara et al 2012</xref>], and left ventricular assist devices have been used while waiting for OLT [<xref ref-type="bibr" rid="propionic-a.REF.ameloot.2011.866">Ameloot et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>OLT in patients with PA is not curative. It does not completely protect against a metabolic stroke, hyperammonemia, or metabolic decompensations.</p>
            </list-item>
            <list-item>
              <p>Life-long post-transplant management is recommended [<xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2004.205">Yorifuji et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.vara.2011.661">Vara et al 2011</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kasahara.2012.230">Kasahara et al 2012</xref>]. Continued protein restriction and L-carnitine supplementation after OLT is advocated by several authors [<xref ref-type="bibr" rid="propionic-a.REF.saudubray.1999.s65">Saudubray et al 1999</xref>, <xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2004.205">Yorifuji et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kasahara.2012.230">Kasahara et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Sedation and perioperative management.</bold> Anesthetic aspects of perioperative management of patients with PA have been infrequently discussed [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. Involvement of a metabolic specialist perioperatively to ensure adequate hydration and caloric management can help minimize the risk of decompensations.</p>
          <p><bold>Emergency situations.</bold> Emergency letters, bracelets, and emergency information in smartphones help facilitate appropriate emergency care by healthcare providers unfamiliar with propionic acidemia.</p>
        </sec>
        <sec id="propionic-a.Prevention_of_Secondary_Comp">
          <title>Prevention of Secondary Complications</title>
          <p>Regular monitoring by a biochemical geneticist and a dietitian is necessary to avoid insufficient or excessive protein restriction. Many factors should be taken into account to guide protein restriction: age, gender, severity of PA, nutritional status, and presence of other factors such as intercurrent illness, surgery, level of physical activity, and growth spurts. The effects of excessive protein restriction can include impaired growth, essential amino acid deficiencies, and metabolic decompensations.</p>
          <p>Acrodermatitis enteropathica, hair loss, and cutaneous <italic toggle="yes">Candida</italic> infections in patients with PA managed with medical foods can be caused by essential amino acid deficiency and require a re-appraisal of the nutritional management.</p>
          <p>Psychotic episodes in patients with PA have been infrequently reported [<xref ref-type="bibr" rid="propionic-a.REF.dejean_de_la_b_tie.2014.274">Dejean de la B&#x000e2;tie et al 2014</xref>]. Similar to other inborn errors of metabolism, care should be exercised when using antipsychotic medications as they can mask clinical signs of encephalopathy or cause adverse effects.</p>
        </sec>
        <sec id="propionic-a.Surveillance">
          <title>Surveillance</title>
          <p>The following evaluations are performed at different intervals depending on factors such as age, disease severity, and presence of catabolic stressors; evaluation frequency can range from every three months to annually.</p>
          <p>Clinical evaluation should include assessment of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Linear growth, weight gain, head circumference, and body mass index</p>
            </list-item>
            <list-item>
              <p>Interval assessment for the need of G-tube</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation including survey for seizures and movement disorders</p>
            </list-item>
            <list-item>
              <p>Interval ophthalmologic evaluation including dilated eye examination</p>
            </list-item>
            <list-item>
              <p>Audiology evaluation</p>
            </list-item>
            <list-item>
              <p>Evaluation for clinical signs of cardiomyopathy (e.g., tachycardia, tachypnea, shortness of breathy, hepatomegaly)</p>
            </list-item>
            <list-item>
              <p>Evaluation of integumentary system (skin, hair, G-tube, and central line insertion sites)</p>
            </list-item>
            <list-item>
              <p>Developmental and neurocognitive progress, as age-appropriate</p>
            </list-item>
          </list>
          <p>Laboratory evaluation should include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Metabolic studies: urine organic acids, pre-prandial plasma amino acids (especially, isoleucine, leucine, valine, threonine, and methionine), plasma ammonia concentration, plasma free and total carnitine, and quantitative plasma acylcarnitine profile</p>
            </list-item>
            <list-item>
              <p>Nutritional studies: electrolytes, mineral panel, albumin, prealbumin, hemoglobin, vitamin D, iron studies, essential fatty acids, and trace minerals (selenium and zinc)</p>
            </list-item>
            <list-item>
              <p>Complete blood count and differential to monitor for cytopenias</p>
            </list-item>
            <list-item>
              <p>Renal function tests; serum cystatin C can be more sensitive than plasma creatinine in identifying early evidence of chronic renal failure.</p>
            </list-item>
            <list-item>
              <p>Amylase and lipase as needed to evaluate for pancreatitis</p>
            </list-item>
          </list>
          <p>Other evaluations:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cardiology evaluation, screening for cardiomyopathy and arrhythmias by echocardiogram, ECG, and Holter monitor, annual and as needed</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation to assess optic nerve and retinal changes, annually and as needed</p>
            </list-item>
            <list-item>
              <p>DEXA scan</p>
            </list-item>
            <list-item>
              <p>Brain MRI, MRS, and EEG as clinically indicated</p>
            </list-item>
            <list-item>
              <p>Physical, occupational, and speech therapy services to determine need</p>
            </list-item>
          </list>
        </sec>
        <sec id="propionic-a.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid prolonged fasting, catabolic stressors, and excessive protein intake.</p>
          <p>Lactated Ringer&#x02019;s solution is not recommended in patients with organic acidemias.</p>
          <p>In patients with QT abnormalities, avoid medications that can prolong the QT interval.</p>
          <p>Ondansetron, an antiemetic drug used to control nausea, has been associated with QT interval prolongation on ECG [<xref ref-type="bibr" rid="propionic-a.REF.tay.2014.9">Tay et al 2014</xref>] and therefore should be used cautiously in patients with PA who have cardiomyopathy and QT interval abnormalities.</p>
          <p>Neuroleptic antiemetics (e.g., promethazine) can mask symptoms of progressive encephalopathy and are best avoided.</p>
        </sec>
        <sec id="propionic-a.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>Testing of at-risk sibs is warranted to allow for early diagnosis and treatment. If prenatal testing has not been performed on at-risk sibs, measure urine organic acids, plasma amino acids, and acylcarnitine profile immediately in the newborn period in parallel with newborn screening.</p>
          <p>See <xref ref-type="sec" rid="propionic-a.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="propionic-a.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Although successful pregnancy outcomes have been reported in patients with PA [<xref ref-type="bibr" rid="propionic-a.REF.van_calcar.1992.641">Van Calcar et al 1992</xref>, <xref ref-type="bibr" rid="propionic-a.REF.langendonk.2012.419">Langendonk et al 2012</xref>], pregnancy can pose a significant management challenge. Hyperemesis gravidarum may require the use of an antiemetic but the risk of QT interval prolongation and the effect on the central nervous system need to be considered [<xref ref-type="bibr" rid="propionic-a.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. Baseline evaluation and monitoring of cardiomyopathy before, during, and after pregnancy is recommended. Reference ranges for total and free plasma carnitine differ during pregnancy [<xref ref-type="bibr" rid="propionic-a.REF.schoderbeck.1995.477">Schoderbeck et al 1995</xref>]. Close nutritional follow up and fetal growth monitoring is necessary as the energy and protein requirements change throughout pregnancy. Close post-partum clinical and biochemical follow up and delayed discharge from the hospital are recommended. In the post-partum period, increased caloric and protein needs during lactation should be taken into consideration.</p>
        </sec>
        <sec id="propionic-a.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="propionic-a.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="propionic-a.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Propionic acidemia (PA) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="propionic-a.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of a <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with PA are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB.</italic></p>
          <p><bold>Other family members.</bold> Each full sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> pathogenic variant.</p>
        </sec>
        <sec id="propionic-a.Carrier_Detection">
          <title>Carrier Detection</title>
          <p><bold>Molecular genetic testing.</bold> Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
          <p><bold>Biochemical testing.</bold> Quantitative plasma amino acids, urine organic acids, acylcarnitine profile, and fibroblast enzymatic analyses are <bold>not</bold> reliable for detection of heterozygotes.</p>
        </sec>
        <sec id="propionic-a.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="propionic-a.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="propionic-a.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">PCCA</italic> or <italic toggle="yes">PCCB</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk for PA and preimplantation genetic diagnosis are possible [<xref ref-type="bibr" rid="propionic-a.REF.alberola.2011.211">Alberola et al 2011</xref>].</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="propionic-a.Resources">
        <title>Resources</title>
      </sec>
      <sec id="propionic-a.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="propionic-a.Molecular_Genetic_Pathogenes">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Propionic acidemia (PA) is an organic acidemia caused by deficiency of propionyl-CoA carboxylase (PCC), a biotin-dependent carboxylase located in the mitochondrial inner space.</p>
          <p>PCC is a heterododecamer (&#x003b1;6&#x003b2;6) composed of six &#x003b1;-subunits encoded by <italic toggle="yes">PCCA</italic> and six &#x003b2;-subunits encoded by <italic toggle="yes">PCCB</italic> [<xref ref-type="bibr" rid="propionic-a.REF.huang.2010.1001">Huang et al 2010</xref>]. The &#x003b2;-subunits form a central core and each of the &#x003b1;-subunits attaches to a &#x003b2;-subunit (see <xref ref-type="fig" rid="propionic-a.F1">Figure 1</xref>).</p>
          <p>PCC catalyzes the conversion of propionyl-CoA to D-methylmalonyl-CoA, which eventually enters the Krebs cycle as succinyl-CoA. Propionyl-CoA is common to the pathway for degradation of some amino acids (isoleucine, valine, threonine, and methionine), odd-chain fatty acids, and cholesterol. Gut bacteria (i.e., <italic toggle="yes">Propionibacterium sp.</italic>) are also an important source of propionate metabolized through PCC.</p>
          <p>The deficiency of PCC enzymatic activity profoundly deranges metabolism at several levels. Possible explanations include:</p>
          <list list-type="bullet">
            <list-item>
              <p>The toxic effects of free organic acids and ammonia;</p>
            </list-item>
            <list-item>
              <p>The accumulation of propionyl-CoA, which in turn can inhibit other enzyme systems including oxidative phosphorylation [<xref ref-type="bibr" rid="propionic-a.REF.de_keyzer.2009.91">de Keyzer et al 2009</xref>], resulting in decreased energy production;</p>
            </list-item>
            <list-item>
              <p>Decreased production of Krebs cycle intermediates.</p>
            </list-item>
          </list>
          <sec id="propionic-a.PCCA">
            <title>
              <italic toggle="yes">PCCA</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">PCCA</italic> is composed of 24 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="propionic-a" object-id="propionic-a.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Most <italic toggle="yes">PCCA</italic> pathogenic variants are private [<xref ref-type="bibr" rid="propionic-a.REF.kraus.2012.51">Kraus et al 2012</xref>]. Approximately 50% of molecularly diagnosed individuals with propionic acidemia harbor pathogenic variants in <italic toggle="yes">PCCA</italic>. Copy number variants are responsible for 18% of the reported variants [<xref ref-type="bibr" rid="propionic-a.REF.campeau.2001.238">Campeau et al 2001</xref>, <xref ref-type="bibr" rid="propionic-a.REF.yang.2004.335">Yang et al 2004</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kaya.2008.558">Kaya et al 2008</xref>, <xref ref-type="bibr" rid="propionic-a.REF.desviat.2009.171">Desviat et al 2009</xref>, <xref ref-type="bibr" rid="propionic-a.REF.aradhya.2012.594">Aradhya et al 2012</xref>].</p>
            <table-wrap id="propionic-a.T.selected_pcca_pathogenic_v" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">PCCA</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.412G&#x0003e;A</td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala138Thr&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000282.3">NM_000282.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000273.2">NP_000273.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_000013.10">NC_000013.10</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.491T&#x0003e;C</td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile164Thr&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.862A&#x0003e;G</td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg288Gly&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.937C&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg313Ter&#x000a0;<sup>1</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1685C&#x0003e;G</td>
                    <td headers="hd_h_propionic-a.T.selected_pcca_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser562Ter&#x000a0;<sup>1</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn>
                  <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cbs.lf1.cuni.cz/pcc/list_of_pcca_mutations.htm">cbs.lf1.cuni.cz</ext-link> for an updated list of <italic toggle="yes">PCCA</italic> pathogenic variants and polymorphisms.</p>
                </fn>
                <fn id="propionic-a.TF.5.1">
                  <label>1. </label>
                  <p>
                    <xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al [2004]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The alpha subunit of PCC has ATP, bicarbonate, and biotin-binding domains, and is responsible for transferring bicarbonate to form carboxybiotin, the first step in the PCC reaction [<xref ref-type="bibr" rid="propionic-a.REF.campeau.2001.238">Campeau et al 2001</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Most pathogenic variants in <italic toggle="yes">PCCA</italic> cause protein instability [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al 2004</xref>].</p>
          </sec>
          <sec id="propionic-a.PCCB">
            <title>
              <italic toggle="yes">PCCB</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">PCCB</italic> comprises 15 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="propionic-a" object-id="propionic-a.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Approximately 50% of molecularly diagnosed cases of propionic acidemia have pathogenic variants in <italic toggle="yes">PCCB</italic>. Three percent of reported variants in <italic toggle="yes">PCCB</italic> are deleterious copy number variants [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2006.992">Desviat et al 2006</xref>, <xref ref-type="bibr" rid="propionic-a.REF.kraus.2012.51">Kraus et al 2012</xref>, <xref ref-type="bibr" rid="propionic-a.REF.chiu.2014.415">Chiu et al 2014</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>The pathogenic variant c.1218_1231del14ins12 is reported to account for approximately 30% of disease-causing alleles in individuals of northern European origin [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al 2004</xref>].</p>
              </list-item>
              <list-item>
                <p>The pathogenic variant c.1304T&#x0003e;C, associated with a milder form of propionic acidemia, accounts for 25% of mutated alleles in Japanese individuals.</p>
              </list-item>
              <list-item>
                <p>Homozygous c.1606A&#x0003e;G (p.Asn536Asp) variant has been identified in Amish and Mennonite communities, in individuals who can initially present with cardiomyopathy.</p>
              </list-item>
            </list>
            <table-wrap id="propionic-a.T.selected_pccb_pathogenic_v" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p>Selected <italic toggle="yes">PCCB</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.280G&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly94Ter</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_3" rowspan="13" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000532.4">NM_000532.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000523.2">NP_000523.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_000003.11">NC_000003.11</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.335G&#x0003e;A</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly112Asp</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.457G&#x0003e;C</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala153Pro&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.502G&#x0003e;A</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu168Lys&#x000a0;<sup>3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1218del14ins12&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly407fs</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1228C&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg410Trp&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1283C&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr428Ile&#x000a0;<sup>2</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1304A&#x0003e;G</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr435Cys&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1495C&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg499Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1534C&#x0003e;T</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg512Cys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1539_1540dupCCC (1540insCCC)</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg514ProfsTer38&#x000a0;<sup>6</sup><break/>(513insP)</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1556T&#x0003e;C</td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu519Pro</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1606A&#x0003e;G&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_propionic-a.T.selected_pccb_pathogenic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn536Asp</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn>
                  <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cbs.lf1.cuni.cz/pcc/list_of_pccb_mutations.htm">cbs.lf1.cuni.cz</ext-link> for an updated list of <italic toggle="yes">PCCB</italic> pathogenic variants and polymorphisms.</p>
                </fn>
                <fn id="propionic-a.TF.6.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="propionic-a.TF.6.2">
                  <label>2. </label>
                  <p>Common in Japan [<xref ref-type="bibr" rid="propionic-a.REF.yang.2004.335">Yang et al 2004</xref>]</p>
                </fn>
                <fn id="propionic-a.TF.6.3">
                  <label>3. </label>
                  <p>Common in Spanish populations [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al 2004</xref>]</p>
                </fn>
                <fn id="propionic-a.TF.6.4">
                  <label>4. </label>
                  <p>Most frequent mutated allele reported in individuals of northern European origin (~30%)</p>
                </fn>
                <fn id="propionic-a.TF.6.5">
                  <label>5. </label>
                  <p>Detected in asymptomatic newborns through newborn screening in Japan; long-term effects are yet to be determined [<xref ref-type="bibr" rid="propionic-a.REF.yorifuji.2002.161">Yorifuji et al 2002</xref>].</p>
                </fn>
                <fn id="propionic-a.TF.6.6">
                  <label>6. </label>
                  <p>Common pathogenic variant among Inuits in Greenland with a carrier frequency in that community of ~5% [<xref ref-type="bibr" rid="propionic-a.REF.ravn.2000.203">Ravn et al 2000</xref>]</p>
                </fn>
                <fn id="propionic-a.TF.6.7">
                  <label>7. </label>
                  <p>A less severe form of PA is seen in some Amish and Mennonite communities.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The beta subunit of PCC has a propionyl-CoA binding site and is responsible for transferring the carboxyl group to propionyl-CoA.</p>
            <p><bold>Abnormal gene product.</bold> Most pathogenic variants are predicted to alter the active site and reduce the enzymatic activity. A smaller percent of pathogenic variants affect subunit interactions, and thus, the assembly of the heterododecamer of PCC [<xref ref-type="bibr" rid="propionic-a.REF.desviat.2004.28">Desviat et al 2004</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="propionic-a.References">
        <title>References</title>
        <sec id="propionic-a.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="propionic-a.Literature_Cited.reflist0">
            <ref id="propionic-a.REF.alberola.2011.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alberola</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bautista-Ll&#x000e1;cer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vendrell</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Mengual</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pardo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calatayud</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Case report: birth of healthy twins after preimplantation genetic diagnosis of propionic acidemia.</article-title>
                <source>J Assist Reprod Genet.</source>
                <year>2011</year>
                <volume>28</volume>
                <fpage>211</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21125326</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.al_essa.1998.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al Essa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahbeeni</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jumaah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Jishi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Amoudi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozand</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <article-title>Infectious complications of propionic acidemia in Saudia Arabia.</article-title>
                <source>Clin Genet.</source>
                <year>1998</year>
                <volume>54</volume>
                <fpage>90</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9727749</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.alhassnan.2003.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Hassnan</surname>
                    <given-names>ZN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyadjiev</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Praphanphoj</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamosh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The relationship of plasma glutamine to ammonium and of glycine to acid-base balance in propionic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>26</volume>
                <fpage>89</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">12872849</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.alshamsi.2014.e42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Shamsi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertecant</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hamad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souid</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Jasmi</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Mutation spectrum and birth prevalence of inborn errors of metabolism among Emiratis: a study from Tawam Hospital Metabolic Center, United Arab Emirates.</article-title>
                <source>Sultan Qaboos Univ Med J.</source>
                <year>2014</year>
                <volume>14</volume>
                <fpage>e42</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24516753</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.ameloot.2011.866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ameloot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlasselaers</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meersseman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desmet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhaecke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyns</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirenne</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassiman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Laet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goyens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malekzadeh-Milan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biarent</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meulemans</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debray</surname>
                    <given-names>FG</given-names>
                  </name>
                </person-group>
                <article-title>Left ventricular assist device as bridge to liver transplantation in a patient with propionic acidemia and cardiogenic shock.</article-title>
                <source>J Pediatr.</source>
                <year>2011</year>
                <volume>158</volume>
                <fpage>866</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21324476</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.aradhya.2012.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aradhya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nwokekeh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stafford</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compton</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchy</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders.</article-title>
                <source>Genet Med.</source>
                <year>2012</year>
                <volume>14</volume>
                <fpage>594</fpage>
                <lpage>603</lpage>
                <pub-id pub-id-type="pmid">22382802</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.arias.2014.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raimann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peredo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valiente</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Parra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bravo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornejo</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia and optic neuropathy: a report of two cases.</article-title>
                <source>JIMD reports.</source>
                <year>2014</year>
                <volume>12</volume>
                <fpage>1</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23818179</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.barshes.2006.773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barshes</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanatta</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Mahony</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpen</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goss</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review.</article-title>
                <source>Pediatr Transplant.</source>
                <volume>10</volume>
                <fpage>773</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">17032422</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.baumgartner.2007.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweigmann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidemia.</article-title>
                <source>J Pediatr.</source>
                <volume>150</volume>
                <fpage>192</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17236900</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.baumgartner.2014.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haliloglu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochuli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballhausen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;nert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honzik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>130</fpage>
                <pub-id pub-id-type="pmid">25205257</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.bergman.1996.404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorland</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <article-title>Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations.</article-title>
                <source>Pediatr Res.</source>
                <year>1996</year>
                <volume>40</volume>
                <fpage>404</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8865276</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.broomfield.2010.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broomfield</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunny</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prabhakar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Spontaneous rapid resolution of acute basal ganglia changes in an untreated infant with propionic acidemia: a clue to pathogenesis?</article-title>
                <source>Neuropediatrics.</source>
                <volume>41</volume>
                <fpage>256</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">21445815</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.campeau.2001.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Structure of the PCCA gene and distribution of mutations causing propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>74</volume>
                <fpage>238</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">11592820</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.chace.2001.2040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chace</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiPerna</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalas</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>EW</given-names>
                  </name>
                </person-group>
                <article-title>Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.</article-title>
                <source>Clin Chem.</source>
                <year>2001</year>
                <volume>47</volume>
                <fpage>2040</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11673377</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.chapman.2012.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stagni</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ah Mew</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Island</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urv</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Acute management of propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>105</volume>
                <fpage>16</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">22000903</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.charbithenrion.2015.786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charbit-Henrion</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacaille</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottolenghi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preece</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharif</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chardot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupic</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Early and late complications after liver transplantation for propionic acidemia in children: a two centers study.</article-title>
                <source>Am J Transplant.</source>
                <year>2015</year>
                <volume>15</volume>
                <fpage>786</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">25683683</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.chiu.2014.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chiu</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>YN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiu</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niu</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ke</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>TT</given-names>
                  </name>
                </person-group>
                <article-title>Two frequent mutations associated with the classic form of propionic acidemia in Taiwan.</article-title>
                <source>Biochem Genet.</source>
                <year>2014</year>
                <volume>52</volume>
                <fpage>415</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">24863100</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.couce.2011.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Couce</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casti&#x000f1;eiras</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f3;veda</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ba&#x000f1;a</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocho</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iglesias</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Col&#x000f3;n</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso-Fern&#x000e1;ndez</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraga</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2011</year>
                <volume>104</volume>
                <fpage>470</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22000754</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.de_baulny.2005.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigal</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Methylmalonic and propionic acidaemias: management and outcome.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2005</year>
                <volume>28</volume>
                <fpage>415</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15868474</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.de_keyzer.2009.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Keyzer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batteux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacaille</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chr&#x000e9;tien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadefeaux-Vekemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria.</article-title>
                <source>Pediatr Res.</source>
                <volume>66</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19342984</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.dejean_de_la_b_tie.2014.274">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dejean de la B&#x000e2;tie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbier</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maltret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brassier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000e9;vent</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadefaux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottolenghi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canou&#x000ef;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Acute psychosis in propionic acidemia: 2 case reports.</article-title>
                <source>J Child Neurol.</source>
                <year>2014</year>
                <volume>29</volume>
                <fpage>274</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24334345</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.delgado.2007.1405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delgado</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mac&#x000ed;as</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Sierra Garc&#x000ed;a-Valdecasas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Portal</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim&#x000e9;nez</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Subacute presentation of propionic acidemia.</article-title>
                <source>J Child Neurol.</source>
                <volume>22</volume>
                <fpage>1405</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18174561</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.desviat.2006.992">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clavero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarrete</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>New splicing mutations in propionic acidemia.</article-title>
                <source>J Hum Genet.</source>
                <volume>51</volume>
                <fpage>992</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17051315</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.desviat.2004.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Pombo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clavero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Propionic acidemia: mutation update and functional and structural effects of the variant alleles.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>83</volume>
                <fpage>28</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">15464417</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.desviat.2009.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Alcudia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarrete</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijzelaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>High frequency of large genomic deletions in the PCCA gene causing propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>96</volume>
                <fpage>171</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19157943</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.dionisivici.2006.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;schinger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhead</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>29</volume>
                <fpage>383</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16763906</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.dionisivici.2002.321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeni</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey.</article-title>
                <source>J Pediatr.</source>
                <year>2002</year>
                <volume>140</volume>
                <fpage>321</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11953730</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.dom_nguezcruz.2011.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dom&#x000ed;nguez-Cruz</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueno-Delgado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereyra</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernabeu-Wittel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conejo-Mir</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Acrodermatitis enerophatica-like skin lesions secondary to isoleucine deficiency.</article-title>
                <source>Eur J Dermatol.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>115</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21224187</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.filipowicz.2006.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Filipowicz</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashurst</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Metabolic changes associated with hyperammonemia in patients with propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>88</volume>
                <fpage>123</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16406646</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.filippi.2010.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Filippi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gozzini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiorini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malvagia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>la Marca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria.</article-title>
                <source>Neonatology.</source>
                <volume>97</volume>
                <fpage>286</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19887858</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.griffin.1996.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hostoffer</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tserng</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebovitz</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppel</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosser</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Parathyroid hormone resistance and B cell lymphopenia in propionic acidemia.</article-title>
                <source>Acta Paediatr.</source>
                <year>1996</year>
                <volume>85</volume>
                <fpage>875</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8819559</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.gr_nert.2012.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gr&#x000fc;nert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;llerleile</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Silva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meissner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ensenauer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodamer</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner-Krainz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haase</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennermann</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinfeld</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beblo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantopoulou</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Teeffelen-Heithoff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwab</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia: neonatal versus selective metabolic screening.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>41</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22134541</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.haan.1985.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bankier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnes</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Severe illness caused by the products of bacterial metabolism in a child with a short gut.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1985</year>
                <volume>144</volume>
                <fpage>63</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">4018104</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.haberlandt.2009.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haberlandt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canestrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner-Krainz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;slinger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mussner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plecko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rost&#x000e1;sy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Epilepsy in patients with propionic acidemia.</article-title>
                <source>Neuropediatrics.</source>
                <volume>40</volume>
                <fpage>120</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20020396</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.h_berle.2012.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;berle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crespo</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servais</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Suggested guidelines for the diagnosis and management of urea cycle disorders.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>32</fpage>
                <pub-id pub-id-type="pmid">22642880</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.hoffman.1991.931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Scientific sleuths solve a murder mystery.</article-title>
                <source>Science.</source>
                <year>1991</year>
                <volume>254</volume>
                <fpage>931</fpage>
                <pub-id pub-id-type="pmid">1948075</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.hsia.1969.757">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hsia</surname>
                    <given-names>YE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scully</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>LE</given-names>
                  </name>
                </person-group>
                <article-title>Defective propionate carboxylation in ketotic hyperglycinaemia.</article-title>
                <source>Lancet.</source>
                <year>1969</year>
                <volume>1</volume>
                <fpage>757</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">4180220</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.huang.2010.1001">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadre-Bazzaz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>ZH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase.</article-title>
                <source>Nature.</source>
                <year>2010</year>
                <volume>466</volume>
                <fpage>1001</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20725044</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.jameson.2008.969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jameson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Cardiac arrest secondary to long QT(C) in a child with propionic acidemia.</article-title>
                <source>Pediatr Cardiol.</source>
                <year>2008</year>
                <volume>29</volume>
                <fpage>969</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">18058159</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.karimzadeh.2014.58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karimzadeh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jafari</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad Abadi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabbedari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taghdiri</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alaee</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghofrani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonekaboni</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nejad Biglari</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia: diagnosis and neuroimaging findings of this neurometabolic disorder.</article-title>
                <source>Iran J Child Neurol.</source>
                <year>2014</year>
                <volume>8</volume>
                <fpage>58</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">24665329</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.kasahara.2012.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakiuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigeta</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishige</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigematsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naiki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R.</given-names>
                  </name>
                </person-group>
                <article-title>Living-donor liver transplantation for propionic acidemia.</article-title>
                <source>Pediatr Transplant.</source>
                <year>2012</year>
                <volume>16</volume>
                <fpage>230</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22151065</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.kaya.2008.558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaya</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Owain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albakheet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colak</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Odaib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imtiaz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coskun</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sayed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hassnan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Zaidan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozand</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Array comparative genomic hybridization (aCGH) reveals the largest novel deletion in PCCA found in a Saudi family with propionic acidemia.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2008</year>
                <volume>51</volume>
                <fpage>558</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">18790721</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.k_lker.2015a.1155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazorla</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teles</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bari&#x00107;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augoustides-Savvopoulou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksglaede</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasco-Alonso</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>I Saladelafont EC, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Gr&#x000fc;newald S, Jalan A, H&#x000e4;berle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, M&#x000fc;hlhausen C, de Baulny HO, Ortez C, Pe&#x000f1;a-Quintana L, Ramad&#x0017e;a DP, Rodrigues E, Scholl-B&#x000fc;rgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015a</year>
                <volume>38</volume>
                <fpage>1155</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">26077420</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.k_lker.2015b.1059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teles</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bari&#x00107;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasco-Alonso</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boy</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cort&#x000e8;s</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saladelafont</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couce</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Meirleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobbelaere</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furlan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradowska</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honzik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;berle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haege</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langereis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;hlhausen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedr&#x000f3;n</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pintos-Morell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena-Quintana</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramad&#x0017e;a</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodrigues</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinera</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Cazorla</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015b</year>
                <volume>38</volume>
                <fpage>1059</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">25875216</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.kraus.2012.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spector</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venezia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creadon-Swindell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;llerleile</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Silva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meissner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ensenauer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodamer</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner-Krainz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haase</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knerr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennermann</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinfeld</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beblo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantopoulou</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Teeffelen-Heithoff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwab</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;nert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis in 54 propionic acidemia patients.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>51</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">22033733</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.laemmle.2014.971">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laemmle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balmer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;berle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia in a previously healthy adolescent with acute onset of dilated cardiomyopathy.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2014</year>
                <volume>173</volume>
                <fpage>971</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24916042</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.lam.2011.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barshop</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cederbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>45-Year-old female with propionic acidemia, renal failure, and premature ovarian failure; late complications of propionic acidemia?</article-title>
                <source>Mol Genet Metab.</source>
                <volume>103</volume>
                <fpage>338</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21549625</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.langendonk.2012.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Langendonk</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angus</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karstens</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klerk</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maritz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachmann</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A series of pregnancies in women with inherited metabolic disease.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>419</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">21918856</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.lee.2009.s97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addonizio</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barshop</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                </person-group>
                <article-title>Unusual presentation of propionic acidaemia as isolated cardiomyopathy.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2009</year>
                <volume>32</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S97</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">19238581</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.lehnert.1994.s68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1994</year>
                <volume>153</volume>
                <fpage>S68</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">7957390</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.li.2015.1208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montenovo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horslen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias.</article-title>
                <source>Liver Transpl</source>
                <year>2015</year>
                <volume>21</volume>
                <fpage>1208</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">25990417</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.manoli.2016.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myles</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shchelochkov</surname>
                    <given-names>OA</given-names>
                  </name>
                </person-group>
                <article-title>Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias.</article-title>
                <source>Genet Med.</source>
                <year>2016</year>
                <volume>18</volume>
                <fpage>386</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">26270765</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.marcadier.2013.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marcadier</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dirbashi</surname>
                    <given-names>OY</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Majewski J, Ferdinandusse S, Wanders RJ, Bulman DE, Boycott KM, Chakraborty P, Geraghty MT. Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>98</fpage>
                <pub-id pub-id-type="pmid">23835272</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.mart_nhern_ndez.2009.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n-Hern&#x000e1;ndez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micciche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachmann</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2009</year>
                <volume>32</volume>
                <fpage>523</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">19629744</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.martinez_alvarez.2016.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martinez Alvarez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jameson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Optic neuropathy in methylmalonic acidemia and propionic acidemia.</article-title>
                <source>Br J Ophthalmol.</source>
                <year>2016</year>
                <volume>100</volume>
                <fpage>98</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">26209586</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.mellon.2000.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellon</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deshpande</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathers</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartlett</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Effect of oral antibiotics on intestinal production of propionic acid.</article-title>
                <source>Arch Dis Child.</source>
                <year>2000</year>
                <volume>82</volume>
                <fpage>169</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">10648377</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.morioka.2005.2754">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morioka</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corrales</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshizawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taira</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshitoshi</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Living donor liver transplantation for pediatric patients with inheritable metabolic disorders.</article-title>
                <source>Am J Transplant.</source>
                <year>2005</year>
                <volume>5</volume>
                <fpage>2754</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16212637</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.m_ller.1980.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;nch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Propionacidaemia and immunodeficiency.</article-title>
                <source>Lancet.</source>
                <year>1980</year>
                <volume>1</volume>
                <fpage>551</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">6102279</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.muro.2001.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Pombo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clavero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Effect of PCCB gene mutations on the heteromeric and homomeric assembly of propionyl-CoA carboxylase.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2001</year>
                <volume>74</volume>
                <fpage>476</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">11749052</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.nizon.2013.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nizon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottolenghi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbier</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habarou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acquaviva</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>148</fpage>
                <pub-id pub-id-type="pmid">24059531</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.north.1995.916">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korson</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gopal</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohr</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brazelton</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisbren</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management.</article-title>
                <source>J Pediatr.</source>
                <year>1995</year>
                <volume>126</volume>
                <fpage>916</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">7539836</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.noval.2013.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noval</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Rodr&#x000ed;guez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-S&#x000e1;nchez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Contreras</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Royo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boto-De-los-Bueis</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Late optic neuropathy in propionic acidemia following surgical intervention.</article-title>
                <source>J Neuroophthalmol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>90</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">23149616</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.nyhan.1999.1143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nyhan</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyer</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Neurologic nonmetabolic presentation of propionic acidemia.</article-title>
                <source>Arch Neurol.</source>
                <year>1999</year>
                <volume>56</volume>
                <fpage>1143</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10488817</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.ottolenghi.2010.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ottolenghi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abermil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aupetit</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaugendre</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morichon-Delvallez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricquier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadefaux-Vekemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Gestational age-related reference values for amniotic fluid organic acids.</article-title>
                <source>Prenat Diagn.</source>
                <year>2010</year>
                <volume>30</volume>
                <fpage>43</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19950217</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.pena.2012.1641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>BK</given-names>
                  </name>
                </person-group>
                <article-title>Survey of health status and complications among propionic acidemia patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>1641</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22678880</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.p_rezcerd_.2000.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Pombo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gangoiti</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz Sala</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Pardo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lama</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murga</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lema-Garrett</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verd&#x000fa;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Potential relationship between genotype and clinical outcome in propionic acidaemia patients.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2000</year>
                <volume>8</volume>
                <fpage>187</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10780784</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.raby.1994.250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raby</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrod</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidaemia and immunodeficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1994</year>
                <volume>17</volume>
                <fpage>250</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">7526032</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.rashed.2001.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases.</article-title>
                <source>J Chromatogr B Biomed Sci Appl.</source>
                <year>2001</year>
                <volume>758</volume>
                <fpage>27</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">11482732</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.ravn.2000.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ravn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chloupkova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonsen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>67</volume>
                <fpage>203</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10820128</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.romano.2010.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jais</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Keyzer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cardiomyopathies in propionic aciduria are reversible after liver transplantation.</article-title>
                <source>J Pediatr.</source>
                <volume>156</volume>
                <fpage>128</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19818452</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.rousson.1984.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rousson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guibaud</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Long term outcome of organic acidurias: survey of 105 French cases (1967-1983).</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1984</year>
                <volume>7</volume>
                <supplement>Suppl 1</supplement>
                <fpage>10</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">6434836</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.sarafoglou.2011.1198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarafoglou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodgers</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hietala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentler</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>EXpanded newborn screening for detection of vitamin b12 deficiency.</article-title>
                <source>JAMA</source>
                <year>2011</year>
                <volume>305</volume>
                <fpage>1198</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">21427371</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.sass.2004.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skladal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayatepek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwahn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperl</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Propionic acidemia revisited: a workshop report.</article-title>
                <source>Clin Pediatr (Phila)</source>
                <volume>43</volume>
                <fpage>837</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15583780</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.sato.2009.790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muguruma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshii</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Liver transplantation in a patient with propionic acidemia requiring extra corporeal membrane oxygenation during severe metabolic decompensation.</article-title>
                <source>Pediatr Transplant.</source>
                <volume>13</volume>
                <fpage>790</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19207227</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.saudubray.1999.s65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouvet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlenzig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narcy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamoun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revillon</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Liver transplantation in propionic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1999</year>
                <volume>158</volume>
                <supplement>Suppl 2</supplement>
                <fpage>S65</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10603102</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.schoderbeck.1995.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schoderbeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legenstein</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevelda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohninger</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes.</article-title>
                <source>J Perinat Med.</source>
                <year>1995</year>
                <volume>23</volume>
                <fpage>477</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">8904477</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.schollb_rgi.2009.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberlandt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gotwald</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner Sigl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauchenzauner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rost&#x000e1;sy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation.</article-title>
                <source>Neuropediatrics.</source>
                <year>2009</year>
                <volume>40</volume>
                <fpage>76</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19809936</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.schreiber.2012.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ah Mew</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stagni</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Island</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urv</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakarapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Neurologic considerations in propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>105</volume>
                <fpage>10</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22078457</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.schulze.2003.1399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlm&#x000fc;ller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olgem&#x000f6;ller</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayatepek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                </person-group>
                <article-title>Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.</article-title>
                <source>Pediatrics.</source>
                <year>2003</year>
                <volume>111</volume>
                <fpage>1399</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">12777559</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.schwahn.2010.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwahn</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieterse</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisset</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galloway</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>PH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>169</volume>
                <fpage>133</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19680687</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.shuaib.2012.799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shuaib</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hashmi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghaziuddin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megdad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abebe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Saif</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doubi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldhalaan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abouzied</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Owain</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia associated with visual hallucinations.</article-title>
                <source>J Child Neurol.</source>
                <year>2012</year>
                <volume>27</volume>
                <fpage>799</fpage>
                <lpage>803</lpage>
                <pub-id pub-id-type="pmid">22156789</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.sipahi.2004.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sipahi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yilmaz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavil</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Propionic acidemia with myelodysplasia and neutropenia in a Turkish child.</article-title>
                <source>J Pediatr Hematol Oncol.</source>
                <volume>26</volume>
                <fpage>154</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15125606</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.stork.1986.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stork</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambruso</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallner</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambrano</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moscinski</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitro.</article-title>
                <source>Pediatr Res.</source>
                <year>1986</year>
                <volume>20</volume>
                <fpage>783</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">3737292</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.surtees.1992.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <article-title>Neurologic outcome of propionic acidemia.</article-title>
                <source>Pediatr Neurol.</source>
                <year>1992</year>
                <volume>8</volume>
                <fpage>333</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1418175</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.sutton.2012.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stagni</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ah Mew</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Island</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urv</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakarapani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Chronic management and health supervision of individuals with propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>105</volume>
                <fpage>26</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">21963082</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.tay.2014.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tay</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ewald</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>FT</given-names>
                  </name>
                </person-group>
                <article-title>Use of QT-prolonging medications in US emergency departments, 1995-2009.</article-title>
                <source>Pharmacoepidemiol Drug Saf.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>9</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">23696066</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.thompson.1990.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliday</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>In vivo propionate oxidation as a prognostic indicator in disorders of propionate metabolism.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1990</year>
                <volume>149</volume>
                <fpage>408</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">2332010</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.touati.2006.288">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mention</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouvet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depondt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souberbielle</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier de Baulny</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2006</year>
                <volume>29</volume>
                <fpage>288</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">16763890</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.van_calcar.1992.641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Calcar</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barness</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Case reports of successful pregnancy in women with maple syrup urine disease and propionic acidemia.</article-title>
                <source>Am J Med Genet.</source>
                <year>1992</year>
                <volume>44</volume>
                <fpage>641</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1481826</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.van_der_meer.1996.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depondt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapoport</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charpentier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamoun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical outcome and long-term management of 17 patients with propionic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1996</year>
                <volume>155</volume>
                <fpage>205</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8929729</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.vara.2011.661">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundy</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heaton</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mieli-Vergani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadzic</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Liver transplantation for propionic acidemia in children.</article-title>
                <source>Liver Transpl.</source>
                <volume>17</volume>
                <fpage>661</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21618686</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.vernon.2014.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vernon</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagnasco</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamosh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperati</surname>
                    <given-names>CJ</given-names>
                  </name>
                </person-group>
                <article-title>Chronic kidney disease in an adult with propionic acidemia.</article-title>
                <source>JIMD Rep.</source>
                <year>2014</year>
                <volume>12</volume>
                <fpage>5</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">23756992</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.woolf.1992.421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woolf</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wynshaw-Boris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Intentional infantile ethylene glycol poisoning presenting as an inherited metabolic disorder.</article-title>
                <source>J Pediatr.</source>
                <year>1992</year>
                <volume>120</volume>
                <fpage>421</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">1538289</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.yang.2004.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kure</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikubo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iinuma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Mutation spectrum of the PCCA and PCCB genes in Japanese patients with propionic acidemia.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2004</year>
                <volume>81</volume>
                <fpage>335</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15059621</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.yorifuji.2004.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurokawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigematsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Living-donor liver transplantation for propionic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2004</year>
                <volume>27</volume>
                <fpage>205</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15159651</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.yorifuji.2002.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muroi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurokawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigematsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsubuchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinical implications.</article-title>
                <source>Hum Genet.</source>
                <volume>111</volume>
                <fpage>161</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12189489</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.zayed.2015.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zayed</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Propionic acidemia in the Arab World.</article-title>
                <source>Gene.</source>
                <year>2015</year>
                <volume>564</volume>
                <fpage>119</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">25865301</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="propionic-a.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="propionic-a.Suggested_Reading.reflist0">
            <ref id="propionic-a.REF.h_berle.2013.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;berle</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.</article-title>
                <source>Arch Biochem Biophys</source>
                <year>2013</year>
                <volume>536</volume>
                <fpage>101</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23628343</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.shah.2013.7423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubbelke</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waheed</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoemaker</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sly</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <article-title>Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both in ammonia detoxification and glucose metabolism.</article-title>
                <source>Proc Natl Acad Sci USA.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>7423</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23589845</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.van_karnebeek.2014.428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CDM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shevell</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zschocke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeschler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2014</year>
                <volume>111</volume>
                <fpage>428</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">24518794</pub-id>
              </element-citation>
            </ref>
            <ref id="propionic-a.REF.van_karnebeek.2014.453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CDM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sly</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvarinova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaplito-Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shyr</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eydoux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newlove</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ukpeh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preece</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ball</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallance</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulter-Mackie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L-H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhavsar</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinclair</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waheed</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasserman</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler-Ipsiroglu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2014</year>
                <volume>94</volume>
                <fpage>453</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">24530203</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="propionic-a.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="propionic-a.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Oleg A Shchelochkov, Dr Carrillo, and Dr Venditti are physicians at the NIH Clinical Center and specialize in pediatrics and biochemical genetics. Dr Carrillo leads the Clinical Section of the Therapeutics for Rare and Neglected Diseases (TRND) Program at the NIH and Dr Venditti is the Director of the Organic Acid Disorder Research Unit at the National Human Genome Research Institute.</p>
        </sec>
        <sec id="propionic-a.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 October 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>17 May 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>28 October 2011 (ncc) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Propionic Acidemia&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="propionic-a.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Metabolic pathway. Propionyl-CoA carboxylase (PCC) catalyzes the conversion of propionyl-CoA to methylmalonyl-CoA, which enters the Krebs cycle via succinyl-CoA. Sources of propionate include: valine, isoleucine, threonine, methionine, odd-chain fatty acids, and cholesterol. Deficiency of PCC results in propionic acidemia (PA) and accumulation of 3-OH propionate, methylcitrate, and glycine, among other metabolites. PCC, located inside the mitochondrion, is a heterododecamer (&#x003b1;6&#x003b2;6) comprising six &#x003b1;-subunits (orange) and six &#x003b2;-subunits (purple). Biotin (blue), bicarbonate, and ATP have binding sites in the &#x003b1;-subunit. The &#x003b2;-subunits form a central core.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="propionic-a-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="propionic-a.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Immediate management and testing algorithm to be pursued simultaneously after the clinical or laboratory suspicion of PA</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="propionic-a-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
